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Cis-regulatory elements (CREs) in the human genome play a critical role
in transcriptional regulation. Alterations of CREs have long been consid-
ered as a major driving force of the human evolution. Recent studies also
suggest that somatic mutations within a CRE can act as drivers in cancer.
With the growth in the quantity and variety of genomic data, more biological
functions of CREs remain to be determined. However, the bottleneck of an-
alyzing human CREs lies in the lack of the holistic approaches to integrating
multi-dimensional genomic data and exploring their roles in human biology.
The primary motivation of this dissertation is to provide novel insights into
the human CREs by developing integrative computational approaches to con-
solidating versatile genomic data. Specifically, we developed three computa-
tional algorithms/frameworks to decipher the complex functions of human
CREs: 1) in the evolutionary context of comparative genomics, 2) in the
context of cancer somatic mutations, and 3) in the context of 3D chromatin
organization.
In the first part of this dissertation, we explored the function of lineage-
specific transcription factor binding sites (TFBS) in the human genome using
ANTICE, a novel probabilistic algorithm developed by us. Compared to pre-
vious methods, ANTICE can predict lineage-specific TFBS under a phylo-
genetic model and also accounts for the uncertainty of the multiple sequence
alignment (MSA) and high turnover rate of TFBS. Based on ANTICE, we
generated by far the largest genome-wide landscape of lineage-specific TFBS
using 680 human ChIP-seq datasets from the ENCODE project. We then
integrated lineage-specific human TFBS with public genomic data. We dis-
covered that a substantial fraction of human TFBS has emerged after the
human-mouse divergence. Younger TFBS, compared to the ancestral TFBS
conserved between human and mouse, tend to locate farther away from the
gene promoters, are more likely to be involved in the tissue-specific open
ii
chromatin regions, and are enriched for common SNPs and germline muta-
tions. Our study provides the first genome-wide landscape of the locations
of lineage-specific TFBS in the human genome, which can help to explain
how human become human in the course of the evolution.
In the second part of this dissertation, we developed an integrated anal-
ysis framework to explore how the genomic context of CREs influence UV
induced mutagenesis at CREs in Melanoma patients. We discovered that the
mutation rates of C to T mutations at tumor-specific DNase I hypersensitive
sites (DHS) are significantly associated with the genomic features of DHS
represented by the distance of DHS to the transcription start site (TSS),
DNA sequence composition of DHS and the H3K4me3 signal of DHS. We
also found that these genomic features often jointly determine the landscape
of the mutation rate at DHS. Within DHS regions, somatic mutations are
enriched at binding sites with CGGAAT or CTCF motifs, which suggests a
potential positive selection phenomenon at CREs in Melanoma. Finally, we
proved that we could accurately predict the profiles of the mutation rate at
CREs using only genomic data through a random forest model. Our study
provides a generic computational approach to prioritize the top players be-
hind the heterogeneity of the cancer mutation rate at CREs, which can not
only explain the biological basis of the mutation variations but also provide
a baseline for identifying drive mutations at CREs.
Finally, we developed a software package named Norma for processing
NGS datasets generated by TSA-seq, a novel technique to measure the three-
dimensional cytological distance of chromatin to a specific nuclear structure.
Norma is an all-in-one software package for TSA-seq data processing, which
covers everything from mapping raw NGS reads and calculating enrichment
scores, to interpreting these scores using functional genomic data. Using
Norma, we determined the spatial organization of the chromatin in K562 cell
relative to the nuclear speckle and the nuclear lamina. We found that ge-
nomic data such as histone modifications, highly expressed genes, and many
sequence features such as the GC content are well organized along the axis
from the nuclear speckle to the nuclear lamina. The computational predic-
tions of the cytological distances by Norma are also consistent with valida-
tions using microscopy. We believe that Norma will become a useful tool for
analyzing TSA-seq data.
In conclusion, in this dissertation, we have provided three computational
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approaches to integrate versatile genomic data on CRE and gained novel
insights on the functions of human CREs.
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1.1 Regulatory regions in the human genome
1.1.1 Regulatory regions are not “junk DNA”
The primary hereditary information for a human being is encoded in a
genome that is approximately 3 billion deoxyribonucleic acid (DNA) base
pairs long, which provides the blueprint for assembling the 3.7 trillion cells
of a typical adult (Bianconi et al., 2013) from a zygote through a series of
differentiation and duplication processes. Soon after the discovery of DNA
as the primary media for inheriting genetic information, scientists have at-
tempted to understand the functions of the 3 billion bp long human genome.
The best-understood fractions of the human genome are the approximately
20,000 protein-coding genes (Ezkurdia et al., 2014). Despite being the origin
of the term “genome,” these 20,000 protein-coding genes merely comprise
approximately about 1.5% of the human genome (Lander et al., 2001).
However, in the last decade, we have witnessed significant challenges in in-
terpreting the remaining 98.5% of the human genome. Initially, a significant
proportion of non-coding DNA (DNA not encoding for proteins) was sus-
pected to be non-functional and was labeled as “junk DNA” (Ohno, 1972).
The debates continued until the launch of the Human Genome Project (HGP)
when scientists were arguing whether to avoid repetitive regions and focus
only on protein-coding regions as sequencing the “junk DNA” would be a
waste of money (Lewin, 1986; Robertson, 1986). Even today, we are facing
a similar question about whether it is worth taking a 50-fold increase in cost
to sequence the whole genome for the sake of the extra genomic informa-
tion as compared to the whole exome sequence strategy in the application
of precision medicine (Ashley, 2016). Interpreting the clinical implications
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of genomic alterations in the non-coding regions is a challenging task. One
of the difficulties in interpreting the functions of non-coding regions stems
from the fact that functions of the non-coding regions are influenced by
the neighboring chromatin context. For example, the transcription activity
of a non-coding DNA fragment integrated into the genome can vary 1000-
folds, depending on its genomic location (Akhtar et al., 2013). In addition,
neighboring and distal non-coding DNA often work together to control gene
expression by being physically close in 3D space (Mercer and Mattick, 2013),
although the mechanism of 3D interactions of non-coding DNA is still not
entirely clear (Alexander et al., 2010). Interpreting the roles of non-coding
regions in various biological processes is currently a popular field in the ge-
nomics community.
Substantial evidence indicates that non-coding regions are important for
transcriptional regulation. For example, many non-coding sequences can reg-
ulate transcription by controlling when a gene is expressed according to cell
type (Smith et al., 2007), developmental stage (Ziller et al., 2015; Yosef et al.,
2013), and environment (Ohmori and Hamilton, 1993). These functional non-
coding DNA sequences capable of controlling gene expression are often called
gene regulatory regions. Recently, as a result of the growing development of
omics-related experimental techniques including ChIP-seq (Johnson et al.,
2007), DNase-seq (Song and Crawford, 2010; Boyle et al., 2008), FAIRE-seq
(Giresi et al., 2007), ATAC-seq (Buenrostro et al., 2013), DNA methylation
profiling (Meissner et al., 2008; Eckhardt et al., 2006; Weber et al., 2005),
Repli-seq (Hansen et al., 2010), and 3-C related techniques (Hughes et al.,
2014; van de Werken et al., 2012; Handoko et al., 2011; Lieberman-Aiden
et al., 2009; Dostie and Dekker, 2007; Dekker et al., 2002), we now have
better functional annotations of the human genome. Genetic, evolutionary,
and biochemical approaches have estimated that between 10% and 80% of
the human genome is functional (Kellis et al., 2014; ENCODE Project Con-
sortium, 2012; Thurman et al., 2012; Garber et al., 2009). Although there is
no unified answer regarding the fraction of regulatory regions among those
functional DNA in the human genome, it is now increasingly clear that much
of the genome is regulatory. Regulatory regions, protein-coding genes, and
proteins form a dynamic regulatory network and precisely control cellular
responses to external stimuli. If we consider the information flow inside a
cell, regulatory regions could be decision-making processing centers that in-
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tegrate input from the environment and proteins bound to the regulatory
regions as shown in Figure 1.1. The outcome would be the precisely con-
trolled transcription of protein-coding genes. Given the large number of
regulatory regions in the human genome and their interactions, much of the
information flow within a cell is dynamically coming to or originating from
regulatory regions.
1.1.2 Why should we study regulatory regions?
Cataloging regulatory regions and understanding their roles are vital to un-
derstanding human biology. First, as mentioned above, the human body
consists of diverse cell types with distinct phenotypes, even though they
share nearly identical genetic information. Analyses of regulatory regions
provide us with a better understanding of how the single genome is dynam-
ically regulated to ensure the diversity of cell types. Second, investigations
of regulatory regions also have clinical implications. Genome-wide associa-
tion studies (GWAS) have revealed that many loci associated with complex
diseases lie in the non-coding regions of the human genome (Maurano et al.,
2012; Chen et al., 2014). The fraction of somatic mutations in non-coding
regions across different cancers are more than 94% (Khurana et al., 2016).
Case studies have revealed that alterations in non-coding regions can cause
cancer. Huang et al. (2013); Horn et al. (2013) found that somatic cancer
alterations can create a new ETS binding site, leading to the binding of ETS
to the TERT promoter, subsequent up-regulation of the TERT gene expres-
sion, and promotion of tumor cell growth. Genomic rearrangements can put
GFI1 and GFIB in proximity to an enhancer, which can further promote
tumorigenesis (Northcott et al., 2014). Lastly, it is now acknowledged that
genetic changes in the gene regulatory sequences of the genome (rather than
in the protein-coding sequences) that result in changes in gene expression are
likely to be the primary cause of the phenotypic differences between human
and closely related primate species (King and Wilson, 1975; Konopka et al.,
2012). Therefore, determining the temporal composition of human regula-
tory elements is the key to understanding the function of the human genome
and explaining the differences between human and other mammalian species.
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1.1.3 Regulatory regions at multiple length scales
At nucleosome level
Broadly speaking, regulatory regions consist of cis-regulatory elements (CRE)
and non-coding ribonucleic acid (ncRNA). In this thesis, we primarily focus
on cis-regulatory elements and their three-dimensional distribution within
the nucleus. Figure 1.2 illustrates the current understandings of the CRE
at different length scales. Regarding functional roles, CRE can be roughly
categorized as promoters, enhancers, silencers, and insulators. Each class
correlates with distinct histone modification profiles (Ernst et al., 2011).
Promoters lie upstream of a target gene and interact with distal enhancers
to initiate gene transcription. Promoters are marked by high levels of tri-
methylation of histone 3 at lysine 4 (H3K4me3), acetylation of histone 3 at ly-
sine 27 (H3K27ac), and the absence of mono-methylation of histone at lysine
4 (H3K4me1) (Ernst et al., 2011). Enhancers are distal regulatory regions
that can enhance target gene expression by interacting with promoters as far
as 1Mb away in both directions (Pennacchio et al., 2013; Lettice et al., 2003).
Enhancers are characterized by high levels of H3K4me1 and H3K27ac and
low levels of H3K4me3 (Ernst et al., 2011). Silencers work against enhancers
to “turn off” target gene transcription. Although the genome-wide locations
of silencers are less well characterized than enhancers, evidence has shown
that a silencer or its ncRNA transcript can recruit polycomb repressive com-
plex 1 and 2 (PRC1, PRC2), drive the H3K27 bi-/tri-methylation of histone,
and repress gene transcription activity (Zhao et al., 2008). Nearby enhancers
or silencers need to be insulated from each other to ensure their functional
effects do not interfere with each other. This is mainly controlled by the in-
sulators. In mammals, CTCF binding sites were thought to be the primary
insulators (Bell et al., 1999), and they are also enriched in the % boundaries
of topologically associating domains (TADs) based on the analysis of Hi-C
data (Dixon et al., 2012). Compared with protein-coding genes, many reg-
ulatory regions are tissue-specific, especially for distal elements (Roadmap
Epigenomics Consortium et al., 2015). These tissue-specific elements are
good predictors of tissue-specific gene expression (Ong and Corces, 2011). In
addition, distribution of regulatory elements is associated with epigenomic
organization, which has been proposed as a major determinant of the cancer
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mutational landscape. Therefore, a comprehensive understanding of reg-
ulatory regions can shed light on any biological processes related to gene
transcription.
The dynamic regulation of regulatory regions is mainly accomplished by
the dynamic bindings of transcription factors (TFs) to DNA according to
cellular states. TFs are a class of proteins that control gene transcription
by binding to specific DNA sequence (called motifs) within the regulatory
regions. The position weight matrix (PWM), also known as the position-
specific scoring matrix (PSSM), is commonly used to depict a motif. PWMs
are usually compiled from multiple sequence alignments (MSA) of TF-bound
sequences that are discovered from experiments (Starling, 2017; Jolma et al.,
2013, 2010; Mukherjee et al., 2004; Carroll et al., 2006) or comparative ge-
nomics methods (Ding et al., 2012; Xie et al., 2005; Stark et al., 2007; Kellis
et al., 2003). Neighboring TF binding sites (TFBS) often form clusters (also
known as cis-regulatory modules or CRMs), keeping the DNA loosely asso-
ciated with histone octamers, the core of nucleosomes. These “unwrapped”
regions are referred to as open, accessible, or nucleosome-depleted regions
(Thurman et al., 2012), which can be mapped using DNase-seq, FAIRE-seq,
or recently developed ATAC-seq. In 2003, the National Human Genome Re-
search Institute (NHGRI) established the Encyclopedia of DNA Elements
(ENCODE) project aiming at comprehensively mapping all the functional
elements, including TFBS, in the genome. After the production phase of the
ENCODE project is finished, it is estimated that 11% of the human genome
is associated with TF bound regions (Kellis et al., 2014; ENCODE Project
Consortium, 2012). TFBS and open chromatin regions comprise approxi-
mately 15% of the human genome (Kellis et al., 2014; ENCODE Project
Consortium, 2012). However, it has estimated that only approximately 5.5%
of the human genome has been under evolutionary constraint (Lindblad-Toh
et al., 2011). Much of the human TFBS undergoes weekly purifying selec-
tions. It is interesting to come to understand the roles of “functionally active
but selectively neutral” TFBS (Kellis et al., 2014).
At chromatin fiber level
Beyond the scale of the nucleosomes, DNA packs into chromatin fibers, and
chromatin fibers further wrap up in multiple scales forming chromosome do-
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mains, compartments, and finally, chromosome territories (Bonev and Cav-
alli, 2016) as shown in Figure 1.2. At a kilobase-scale to a megabase-scale,
chromatin can bend into loops (Rao et al., 2014) or form localized frequently
interacting regions (FIREs see Schmitt et al. (2016)). One well-known class
of loops is the enhancer-promoter loop, which up-regulates the expression of
the target gene in the cell type where the loop is present (Rao et al., 2014;
Pomerantz et al., 2009). Beyond the chromatin loop, chromatin folds into
domains (e.g., TADs), in which regions within the same domain interact with
each other much more frequently than with regions located in adjacent do-
mains (Nora et al., 2012; Sexton et al., 2012; Dixon et al., 2012). Strikingly,
these domains are associated with megabase-scale epigenetic signatures (Sex-
ton et al., 2012), enriched with CTCF (Dixon et al., 2012), and also have
a similar size to genome replication timing domains (Pope et al., 2014). In
Drosophila, TADs correspond to the bands in polytene chromosomes, which
connect regulatory regions with microscopy observations (Eagen et al., 2015).
At the highest level, chromatin further folds into compartments and territo-
ries (Rao et al., 2014; Lieberman-Aiden et al., 2009). Initially, analysis of
the interactions between TADs revealed two types of compartments, called
A and B, which are enriched with active and inactive chromatin, respectively
(Lieberman-Aiden et al., 2009). TADs interact mostly with other TADs from
the same type of compartment, even if they are far away in the linear chro-
mosome (Lieberman-Aiden et al., 2009). Recently, higher resolution Hi-C
(Rao et al., 2014) suggests that A/B compartments can be further divided
into two (A1, A2) and four subcompartments (B1, B2, B3, B4). Interest-
ingly, B2 and B3 subcompartments are found to be enriched at the nuclear
lamina and the nucleolus, respectively (Rao et al., 2014). Independent of
3C-based methods, Guelen et al. (2008) developed the lamin-DamID to score
the DNA contact with nuclear lamina by fusing a DNA adenine methyltrans-
ferase (Dam) to lamin B1 protein. They reported that approximately 40% of
the human genome consists of 0.1-10Mb lamin-associated domains (LADs)
that are attached to the nuclear lamina. How and to what extent those sub-
compartments connect to different nuclear structures, such as the nuclear
speckles, in the nucleoli are not quite clear. Although how 3D chromatin or-
ganization is established remains unknown, several studies have highlighted
the roles of the 3D chromatin structure in gene transcription. Therizols et al.
(2014) found that temporal gene expression changes during the differentia-
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tion process are associated with the gene movement relative to the nuclear
periphery. Artificial tethering of a transcriptional repressor to the genome is
sufficient to shift TADs and alter gene expression as shown by Wijchers et al.
(2016). Currently, there is still no theory of how transcription is controlled at
the compartment level. It is interesting to examine the relationship between
3D chromatin organization and the transcription activity regulation at the
compartment level.
In summary, regulatory regions represent a significant fraction of the hu-
man genome. The roles of regulatory regions in 3D chromatin organization
represent an active research area with rapid developments. Currently, what
we know perhaps is only the tip of the iceberg of chromatin biology.
1.2 Challenges to studying functions of regulatory
regions
Currently, the study of regulatory regions is still in its first phase, which
has been primarily focused on determination of the genome-wide locations of
regulatory regions. There are still many unsolved questions on the roles of
regulatory regions, such as its relationship with transcription, diseases, and
evolution. What makes studying regulatory elements so difficult?
Firstly, regulatory regions and their interactions or named regulome are
dynamic in different cellular conditions and evolution as well. The human
regulome varies in many dimensions, such as cell types, development stages,
cell cycles, and the environment. The same regulatory region can regulate
different genes in different cell types. Therefore, the roles of regulatory re-
gions must be carefully stated in a specific context, as comprehensively ex-
amining combinations of every dimension is an infeasible task. Additionally,
the evolution of regulatory regions is highly dynamic. Indeed, substantial
experimental evidence has shown that TFBS turnovers are pervasive across
species (Schmidt et al., 2010; Borneman et al., 2007; Odom et al., 2007;
Moses et al., 2006). An initial functional study on 20 regulatory regions
in the human genome estimated that 32% to 40% of regulatory regions in
the human genome are not functional in mouse cells (Dermitzakis and Clark,
2002). A genome-wide ChIP-seq analysis of four TFs between the human and
mouse liver cells concluded that between 41% and 89% of the human TFBS
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seem to be species-specific (Odom et al., 2007). Our computational model
branch-of-origin (BOO) predicted that 58% to 79% of human TFBS from
six TFs originated after human-mouse divergence (Yokoyama et al., 2014).
TFBS turnover is important in distinguishing humans from our closest rela-
tives, chimpanzees. Humans and chimpanzees are very similar in terms of the
sequence of protein-coding genes. However, despite the high sequence simi-
larity, it is clear that there are many phenotypic differences between the two.
What is the genetic basis for the differences? It is now acknowledged that
regulatory regions play a major role in guiding the evolution of gene regula-
tion (King and Wilson, 1975; Shibata et al., 2012). Therefore, understanding
the evolutionary history of CRE is important in studying human-specific bi-
ology. Currently, the genome-wide locations of TFBS from many TFs are
available from public resources, such as ENCODE. However, there is no study
to comprehensively examine the proportion of human-specific TFBS.
Second, it is difficult to identify regulatory regions associated with diseases.
Case studies have found that disruptions of regulatory regions can disturb
gene transcription and can ultimately cause diseases. Driscoll et al. (1989)
found that deletions of several DNase-I hypersensitivity sites (DHS) cause
thalassemia. Lettice et al. (2003) discovered that enhancer 1Mb away from
the SHH gene is associated with preaxial polydactyly. However, few com-
putational methods can accurately prioritize regulatory region alterations
responsible for diseases, in essence, connecting genotype to phenotype. Iden-
tification of variants that can break existing TFBS or create new TFBS is a
good strategy for narrowing down the list of candidates as shown by FunSeq
(Khurana et al., 2013; Fu et al., 2014). However, these kinds of methods have
limited powers to predict the consequence of the variants. Assessment of the
functional effect of the alterations is still difficult because of two caveats. The
first caveat is that the assignment of a regulatory region to its target gene is
non-trivial. The second caveat is that the alterations of regulatory regions
might only have subtle functional effects that are invisible in a single locus
unless we aggregate data from the entire genome or across multiple patients.
For example, Perera et al. (2016a) recently found that TFs can interfere with
nuclear excision repair (NER), causing the mutation rate to elevate at DHS
in the transcription initiation sites. They found this observation by aggre-
gating thousands of DHS, which cannot be observed in a single DHS. Other
roles of regulatory regions in diseases, including the connection between 3D
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chromatin interaction and cancer structure variants, remain to be answered.
Third, experimental or computational approaches to studying the spatial
distributions of regulatory regions and their roles in 3D chromatin organi-
zation are still limited. Historically, many basic principles of chromatin 3D
organization were uncovered by microscopy. For example, light and electron
microscopy confirmed the existence of many subnuclear organelles, such as
nuclear speckles (Spector and Lamond, 2011), nuclear nucleolus (Pederson,
2011), and Cajal bodies (Gall, 2000). Microscopy observation is straight-
forward but has some drawbacks, such as its low throughput and low res-
olution. Since 1993, many techniques based on the nuclear ligation assay
(Cullen et al., 1993) have been developed, such as 3C-based methods. Us-
ing these techniques, striking correlations have been revealed between the
higher levels of chromatin folding (such as compartments, TADs, etc.) and
many functional genomic signals, such as DNA replication timing, and tran-
scriptional activity. Although 3-C based methods can ideally reconstruct the
3D positioning of chromatin, the reconstruction process requires substantial
modeling and theoretical assumptions, such as how to convert the contact fre-
quency of Hi-C matrix to the distance in the three-dimensional space. There
is a big gap between the nuclear organizations visualized by microscopy and
the 3D spatial distributions of regulatory regions inside the nucleus.
1.3 Contribution of the thesis
The primary focus of this thesis is to provide novel angles to computation-
ally analyze human regulatory regions and comprehensively annotate their
functions. Specifically, the three studies in this thesis aim to solve the three
challenges mentioned above, in essence, deciphering the complex functions
of the human CRE: 1) in the evolutionary context of comparative genomics,
2) in the context of cancer somatic mutations, and 3) in the context of 3D
chromatin organization.
In Chapter 2, we will describe a computational method to trace the
evolution of the human TFBS using a birth-death probabilistic model. The
pilot study of six TFs showed that substantial human TFBSs are lineage-
specific. Now, our study of human TFBS from 680 ENCODE ChIP-seq data
has shown that fractions of lineage-specific TFBS are substantial for most
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TFs. We also discovered that those TFBSs with distinct branch-of-origin
might possess different functions regarding their genomic distribution, tissue
usage, and susceptibility to single nucleotide variants (SNV). By providing
the first comprehensive map of lineage-specific TFBS in the human genome,
our results will provide insights on the patterns of TFBS evolution and how
they have led to human-specific phenotypes. This will, in turn, help us better
understand human biology and disease mechanisms.
In Chapter 3, we will describe an integrated analysis of how local ge-
nomic context can affect the cancer somatic mutation rate at DHS or TFBS.
At scales ranging from several to hundreds of base pairs, two recent studies
(Perera et al., 2016a; Sabarinathan et al., 2016) found that mutation rate
increases at DHS or TFBS locating within active promoters, as TF binding
to chromatin can block NER machinery from accessing DNA. To compre-
hensively understand the mechanisms behind the elevated mutation rate at
regulatory regions, we examined mutation rate variations within DHS un-
der various genomic contexts in 183 patients with melanoma. Surprisingly,
we found that local genomic features (such as the closest distance to down-
stream TSS, GC content, and H3K4me3 histone modification) significantly
connect to the mutation rate at DHS, which cannot be solely explained by
NER variations. In addition, we noticed that binding sites with a CGGAAT
motif pattern and CTCF binding sites in intergenic regions show much higher
mutation rates compared with TFBS flanking regions, which suggests a po-
tential positive selection on regulatory elements in melanoma. Our study
is an important extension of recent works by Perera et al. (2016a); Sabari-
nathan et al. (2016). These observations reveal a complicated relationship
between regulatory regions, genomic features, and cancer somatic mutations.
We believe that future methods aiming to prioritize driver regions from hy-
permutated non-coding regions should consider local genomic context.
The study of regulatory regions has also led to another direction: the
exploration of the cytological distance of chromatin to specific nuclear struc-
tures. The genome’s 3D organization plays a vital role in transcriptional
regulation and the preservation of normal genome function. Traditional mi-
croscopy approaches to measuring the cytological distances of chromosome
loci from particular nuclear structures are low throughput and low resolu-
tion. In Chapter 4, we described the first computational tool for handling
and analyzing TSA-seq data, a novel technique developed by Dr. Andrew
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Belmont’s laboratory to measure the cytological distance of chromatin to a
specific nuclear structure, such as the nuclear speckle and the nuclear lamina.
Our tool automates all the analysis steps, including handling raw sequencing
reads, signal normalization, and conducting all kinds of the integrated anal-
ysis of enrichment scores using functional genomic data. Applying this tool
to SON TSA-seq and LaminB TSA-seq data in K562 cell line, we found that
with increasing proximity to the nuclear speckle, chromatin is enriched with
active histone marks and high expressed genes. We also found that there are
two types of transcription hot-spot regions, primarily corresponding to the
A1 versus A2 subcompartments. These two subcompartments have compa-
rable transcription activity; however, they are located far from each other
based on their cytological distance from the speckle.
Finally, in Chapter 5, we provide a summary of this thesis, its limitations
and directions for future work.
1.4 Figures and Tables
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Figure 1.1: Summary of the information flow within a cell. Protein-coding
DNA only represents 1.5% of human genome. The rests are repeats and reg-
ulatory regions. The width of the arrow indicates the volume of information.
Regulatory regions, environment, and DNA binding proteins work together
to regulate transcription and replication of protein-coding genes.
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Figure 1.2: Regulatory regions in the human genome exist at different scales.
The top left shows the landscape inside an interphase mammalian cell nu-
cleus. Chromatin fibers from different chromosomes occupy distinct terri-
tories (denoted by different colors). Rectangles indicate regions that are
shown at higher magnification and increased resolution in next panel. At
high resolution, TADs, convergent CTCF TFBS pairs, and cohesin complex
are shown. Convergent CTCF and cohesin complex form a typical chromatin
loop. Next, four types of regulatory elements (promoter, enhancer, silencer,
and insulator) are shown with a zoom-in view showing the primary compo-
nents of the transcription regulatory machinery at gene promoters. Finally,




CIS-REGULATORY ELEMENTS IN THE
HUMAN GENOME
2.1 Background
It is now acknowledged that genetic changes in the gene regulatory elements
in the non-coding regions of the human genome are likely to be the main
cause of the phenotypic differences between human and other mammalian
species. At the level of transcription, recent evidence has shown that the
modifications of gene regulation mostly consist of the acquisition and the
loss of 6bp-30bp cis-regulatory elements (CRE), such as transcription factor
binding sites (TFBS) (Wray et al., 2003; Wittkopp and Kalay, 2011; Carroll,
2008). Alterations in CRE rather than in protein-coding genes have been
found to be responsible for molecular and organismal phenotype divergence
and have been associated with diseases (Wittkopp et al., 2008; Maurano
et al., 2012; Lynch and Wagner, 2008; Khurana et al., 2013). Recent stud-
ies have also revealed the connection between TFBS alterations and changes
in 3D chromosome architecture (Zuin et al., 2014; de Wit et al., 2015; Vi-
etri Rudan et al., 2015). The long-term goal of comparative genomics is to
better understand the relationship between genomic differences and pheno-
typic diversities across species, which will, in turn, help us understand the
human genome and identify key variants related to diseases.
However, several challenges exist in the study of the evolution of TFBS.
First, most TFBS are located in the non-coding regions with a low degree of
sequence similarity across species (Griffon et al., 2015; Kim and Ma, 2011;
Chen and Tompa, 2010). Second, substantial experimental evidence has
shown a rapid divergence of TFBS among mammals (Sundaram et al., 2014;
Schmidt et al., 2010; Odom et al., 2007; Bourque et al., 2008). However,
current computational methods designed to analyze regulatory element evo-
lution have limited ability to study the evolution of lineage-specific TFBS.
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Two computational approaches have been used to study the evolution of
lineage-specific TFBS. The first method relies on cross-species alignment for
detecting the rapid emergence or loss of CRE along a species or clade in the
phylogeny. Studies using this approach have identified many human acceler-
ated CRE that can drive human-specific gene expression pattern (Prabhakar
et al., 2006; McLean et al., 2011; Lowe et al., 2011; Gittelman et al., 2015;
Bird et al., 2007). The weakness of these methods is that TFBS turnover is
not included in the model and thus cannot explicitly predict gains or losses
on TFBS on a given branch in phylogeny. The second approach incorporates
TFBS turnover into the sequence evolution model (Ray et al., 2008; Moses
et al., 2006). These methods have shown promising results, but their main
limitation is that the performance depends on extensive training data which is
difficult to find. More importantly, both of those methods use the nucleotide-
by-nucleotide information from multiple sequence alignment (MSA), which
has been shown to be error-prone in non-coding regions (Ezawa, 2016; Lan-
dan and Graur, 2009; Lunter et al., 2008). Previous studies have estimated
that more than 15% of aligned bases in human-mouse whole-genome align-
ment is incorrect (Lunter et al., 2008), and the error increase as the number
of species in MSA increases (Chen and Tompa, 2010; Kim and Ma, 2011).
Until now, no computational methods have been able to specifically predict
linages-specific TFBS alterations using the phylogenetic model and also allow
for the uncertainty of MSA and the high turnover rate of TFBS. Therefore,
there is an urgent need to develop an algorithm that can overcome these
limitations.
In this chapter, we describe a novel computational framework called AN-
TICE1(Annotating TFBS In the Context of Evolution, see Section 2.2) with
improvements from our previously developed probabilistic model BOO (rep-
resenting “branch of origin”) (Yokoyama et al., 2014) to comprehensively
identify lineage-specific TFBS. ANTICE produces accurate predictions of
TFBS locations along with the improved prediction of the branch of ori-
gin of TFBS in the human genome. In order to understand the principles
of lineage-specific TFBS mediated gene regulation evolution, an integrative
analysis of genome-wide lineage-specific TFBS is needed. Therefore, we ap-
plied ANTICE to large-scale ChIP-seq data collected from the ENCODE
project (Section 2.4). We found that a considerable proportion of hu-
man TFBS are lineage-specific with estimated branch-of-origin originated
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after the human-mouse split. In addition, as compared with the ancestral
TFBS, younger TFBS have a distinct preference for genomic distribution
and tissue usage specificity. In addition, they are susceptible to common
single-nucleotide polymorphism (SNP). We also observed an enrichment of
the transposable element (TE) on TFBS, highlighting TE-driven TFBS ex-
pansion events.
2.2 The ANTICE algorithm framework
The ANTICE framework is illustrated in Figure 2.1. The sample-dependent
inputs include the locations of ChIP-seq peaks in the species of interest (e.g.,
human) and the motif PWMs of target TFs. Sample-independent inputs
include the vertebrate MSA and the species phylogenetic tree associated
with the MSA. Although the orthologous regions are obtained from MSA,
the base-by-base details of MSA are ignored in ANTICE.
The first step of ANTICE is to search for TFBS in each species under
the alignment block of each ChIP-seq peak. ANTICE uses the motif PWM
model to search for motif occurrences in MSA. There are several reasons
we choose PWM rather than over-represented k-mer, which is implemented
in BOO. First, BOO has poor performance when the k-mer length is large.
The program takes days to search binding sites with a 15-bp-long motif as
the running time increase exponentially with the size of k-mer. Second, the
threshold for determining a k-mer as a binding site or not is dataset-specific,
which makes comparisons between datasets impossible. Third, BOO assumes
only one motif exists in each ChIP-seq dataset. This assumption is challenged
by recent studies that show secondary motifs are prevalent in real ChIP-seq
data (Wang et al., 2012). Here, in the ANTIVE algorithm framework, the
cutoff is determined by P value, allowing us to set a universal threshold when
we integrate results from multiple TF ChIP-seq datasets. Also, the primary
motifs and secondary motifs can be modeled separately using distinct PWMs.
Next, using the intermediate results (number of TFBS per species) along with
1Part of this study appeared as an article in the Journal of PLoS Computation Biology
authored by me. The original citation is as follows: Yokoyama KD†, Zhang Y† and
Ma J. Tracing the Evolution of Lineage-Specific Transcription Factor Binding Sites in a
Birth-Death Framework. PLoS Computational Biology, 10(8):e1003771, 2014 (†: equally
contributed Author)
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the phylogeny of species, a birth-death model (see details in Section 2.2.1)
is built to quantify the log-likelihood of the phylogeny (see details in Sec-
tion 2.2.2 and Section 2.2.3). An EM algorithm will iteratively update
the parameters until convergence is reached. Finally, by tracing back from
the leaf node to the root of the phylogenetic tree, ANTICE reports the esti-
mated branch-of-origin of TFBS in ChIP-seq peak regions. We compared the
performance of ANTICE to that of BOO using several benchmark datasets.
Overall, ANTICE outperforms BOO in most cases (see details in Section
2.3).
2.2.1 Birth-death probability model
We assume the evolution of TFBS can be modeled as a combination of birth
process and death process (Cavender, 1978). The parameters of these two
processes are the birth rate (α) and the death rate (β), respectively. The
birth rate (α) represents the probability that a new binding site appears
at an unoccupied nucleotide per year. The death rate (β) represents the
probability that an existing binding site is lost per year.
Suppose w(t) is the probability that a TFBS exists in time t. Then, the
probability of observing a binding site at the same position in time t + 1
under the birth-death model is:
w(t+ 1) = α(1− w(t)) + (1− β)w(t) (2.1)
The changing rate of the probability w(t) can be written as w′(t) = w(t+
1)− w(t), which can be calculated as:
w′(t) = α− (α + β)w(t) (2.2)
Solving this equation gives two solutions depending on whether there is a

















Note that u(t) is when w(0) = 1, and v(t) is when w(0) = 0.
In a region with N nucleotides, suppose there are i occupied binding sites










Similarly, the probability that there are b binding sites generated from
N − i unoccupied nucleotides is:
VN−i,b(t) =
(N − i)!
(N − i− b)!b!
v(t)b(1− v(t))N−i−b, b ∈
[
0, N − i
]
(2.6)
, where the transition probability pij(t) represents the probability that the
given region has j binding sites after time t with initial binding site number




Ui,k(t) · VN−i,j−k(t) (2.7)
2.2.2 Calculating the likelihood of the data
To calculate the likelihood of the data with a given phylogenetic tree, we used
the Felsenstein’s pruning algorithm (Felsenstein, 1973). Firstly, we assume





Let DY represents the data under a subtree of node Y , and let Z1 and Z2
be two children of the node Y , with speciation time tZ1 and tZ2 relative to
their parent node Y , respectively. Assuming there are i binding sites in the
parent node Y , the likelihood of node Y is:
xY (i; θ) =
2∏
k=1
pij(tZk) · xZk(j; θ) (2.8)
If Zk is a modern lineage, the probability XZk(j, θ) is 1 if and only if there
are exactly j binding sites observed within N nucleotides in the node Zk.
Otherwise, the probability XZk(j, θ) is 0.
Recursively traversing from the leaves to the root of the phylogenetic tree,
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the log-likelihood L(DR; θ) for a N nucleotides-long region can be written as
:















Here, P (j) is the prior probability which is set to follow the Poisson dis-
tribution: P (j) = λ
je−λ
j!
, in which λ is the mean number of the binding site
across the tree.
2.2.3 Determining the optimal ancestral state
Under the birth-death model, the potential number of TFBS (state) in each
node of the phylogenetic tree ranges from 0 to N . In practice, it is extremely
rare that the number of TFBS is close to N . Therefore, we use N̂ to represent
the max possible number of TFBS which can be defined by users. By default,
N̂ is set to be 25 or the max number of TFBS found in extant species,
whichever is larger.
In ANTICE, we applied a dynamic programming approach to calculating
the optimal number of TFBS (state) in each ancestral node. Firstly, we
construct two N̂ ×M matrices T1 and T2, in which M means the number of
nodes in the rooted phylogenetic tree and N̂ is the max number of TFBS per
node in the phylogenetic tree. We store the max log-likelihood of each node
given all the possible states of its children in the T1, e.g., T1[jY , Y ] represents
the max log-likelihood given the number of TFBS of node Y is jY . In T2, we
store the path generating the max log-likelihood from children to the parent.
To calculate these two matrices, we traverse the tree in a postorder manner.
If the child node Z is a leaf node with X binding sites, T1[jZ , Z] is initial-
ized as 0.0, in which jZ equals X. Otherwise, T1[jZ , Z] is set as −10000.0
representing an extremely small probability. For the parent node Y , the
max log-likelihood for each possible numbers of jY ∈ [0, N̂ ] is determined by
taking the maximum from all the possible combinations of children states
via:
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T1[jY , Y ] = arg max
jZ1 ,jZ2
(










, in which T2[jY , Y ] stores the optimal number of TFBS for two children
nodes Z1 and Z2. This process is repeated from the leaves to the root of the
tree until all the elements in the matrix T1 and T2 are filled.
At the root node R, the most likely ancestral state is the one that has
the max log-likelihood. Finally, we use matrix T2 to trace back the path
associated with the max log-likelihood. Therefore, the ancestral state of
each ancestral node is finalized. The time complexity of this algorithm is
O(M × N̂2) because we need to calculate log-likelihood for N̂ times for each
element in matrix T1.
2.2.4 Birth-death rate estimation
The birth and death rates can be estimated iteratively. We use the EM-based
approach (Dempster et al., 1977) to iteratively optimize the likelihood given




. The initial values of α and β are determined by
empirical ancestral states using parsimony. We found that the final values
of α and β were not sensitive to initial estimates. We then determine the
optimal number of TFBS for each internal node using initial α and β as shown
in Section 2.2.3. The optimal number of birth and death events is known
while we trace back from the root to leaves of the tree. We re-estimate α by
dividing the total number of the birth events by the product of total evolution
time of phylogenetic tree and the total length of unoccupied nucleotide. β is
determined in a similar way except using total length of binding sites. The
process of re-estimation of the optimal ancestral state with new α and β will
continue until convergence is reached.
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2.3 Evaluation on benchmark data
We evaluated the performance of ANTICE on benchmark datasets on the
following aspects
Comparison with BOO
We compared ANTICE with BOO on the same benchmark dataset based
on six ChIP-seq datasets from the human-mouse analogous cell lines. Un-
like BOO, which used PWM built from over-represented k-mer under peak
regions, ANTICE used PWM from the public motif database. To make a
fair comparison, we defined the positive cases (conserved TFBS originated
before human-mouse common ancestor) as the 200bp regions centered on the
human ChIP-seq peak summits that have a shared peak in the analogous
mouse cell with the mouse peak summit within +/-200bp of the human peak
summit. Negative cases were defined as the 200bp regions centered on the
human ChIP-seq peak summits that did not have shared peaks in the mouse
cell. ANTICE had better accuracy on all the six TF ChIP-seq data compared
with BOO as shown in Figure 2.2. Although none of the motif information
was used in the benchmark construction process, we observed better perfor-
mance for motifs in public database than motifs de novo identified using the
k-mer based method. For example, the result of SOX2, whose k-mer based
motif PWM is the most different from the one in the public motif database,
had the greatest improvement in accuracy. This result suggests that using a
well-characterized motif is important in identifying motif matches and thus
improve model accuracy.
Comparison with other methods based on MSA
Next, we evaluated ANTICE on experimental data with other competing
methods based on the nucleotide-by-nucleotide information from MSA. We
compared ANTICE with GERP and phyloP on 20 benchmark datasets con-
structed based on the ChIP-seq datasets from five species (human, rhesus,
mouse, rat, and dog) for five TFs (CTCF, CEBPA, FOXA1, HNF4A, HNF6)
(Schmidt et al., 2012; Ballester et al., 2014). For example, the human-
mouse benchmark data for CTCF contains conserved CTCF TFBS before
21
the human-mouse split (positive cases) and lineage-specific TFBS originated
after the human-mouse last common ancestor (negative cases). PhyloP scores
were calculated using MSA. To reduce the bias from unrelated species in
MSA, for human-rhesus benchmark data, we used primate phyloP scores
while we used mammal phyloP scores for other benchmark data. We cal-
culated the area under the ROC curve (AUROC) when varying thresholds
were used to predict lineage-specific TFBS. The detailed comparison is sum-
marized in Table 2.1. In all the linage-specific benchmark data, ANTICE
outperformed other methods for four TFs except for HNF6. For HNF6,
ANTICE had a much higher performance for human-rhesus benchmark data
while the performances for the ancestral TFBS (older than the human-rhesus
last common ancestor) were comparable with GERP or phyloP scores. Over-
all, ANTICE has the best improvement in young TFBS as compared with
ancestral TFBS. These results highlight the advantage of our method for
predictions of lineage-specific TFBS.
Despite the TFBS motif being vital to the accurate inference of TFBS
evolution, the performance of ANTICE is not sensitive to motif calling P
value cutoffs as shown in Figure 2.3. F1 scores (a balanced evaluation of
both precision and recall) of ANTICE for five TFs drop slightly as long as
the P value cutoff remains in a reasonable range (i.e., below 1e − 4, the
default setting in many motifs searching tools, such as FIMO). In contrast,
the performance of GERP is strongly associated with the cutoff of TFBS
identification. As Figure 2.3 has shown, when the GERP score cutoff is
around 2, the F1 score for the CTCF benchmark drops to 0, while F1 scores
for the other four TFs reach their maximum. Therefore, it has been very
difficult to obtain a threshold with good performance for only five TFs, let
alone we plan to analyze dozens of TF ChIP-seq datasets. In practice, since
decreasing the threshold of P value would also reduce the number of TFBS
predicted, we reasoned that 1e-5 would be a reasonable threshold, balancing
both method accuracy and the number of the predicted TFBS.
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2.4 Comprehensive evolutionary annotation of human
TFBS based on ENCODE data
Rapid accumulation of ChIP-seq data (e.g., those from the ENCODE project)
provides an unprecedented opportunity to identify and annotate functional
elements in the human genome. Here, we compiled 680 human ChIP-seq
datasets from the ENCODE project coming from 163 TFs. We applied a
de novo motif searching pipeline to these 680 ENCODE human ChIP-seq
datasets (see Section 2.5.1). 393 primary motifs (75 TFs) from 355 ChIP-
seq experiments and 638 secondary motifs from 358 samples were identified.
The number of samples with either a primary motif or secondary motif is 541
(79.5%). In this study, we focused only on the primary motifs since they are
more likely to be the direct motifs bound by the TFs. 393 primary motifs
were clustered into 43 groups based on the normalized correlation coefficient
calculated by the matrix-clustering program from the RSAT tool (Figure
2.4). As expected, we found that primary motifs from the same TFs tend to
be in the same cluster. For example, motifs from CTCF ChIP-seq datasets
formed a tight cluster containing all the CTCF data (more than 90 ChIP-seq
samples in different cell types). Among the 75 TFs with primary motifs, 8
TFs, such as NR2C2 and REST, had primary motifs in multiple clusters. For
the remaining TFs, primary motifs from one TF were grouped in one motif
cluster. Some TFs, such as FOS, JUN, and JUND belong to the same motif
cluster. This is consistent with the previous finding that these TFs bind to
the same consensus motif TCACGT (Manna and Stocco, 2007). For motifs
within a cluster, motifs from the same cell line are more similar than motifs
from different cell types, as shown in the CEBPE motif cluster (Figure 2.4).
In summary, these primary motifs can recapitulate the known TF binding
motifs.
2.4.1 Substantial human TFBS are originated after the
human-mouse split
For the 355 samples with primary motifs, genome-wide lineage-specific TFBS
were predicted using the PWMs of primary motifs with motif searching cutoff
P value < 1e-5. Surprisingly, we found that the fraction of the ancestral
TFBS (present in the human-mouse last common ancestor) covered a large
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range. The percentage of the ancestral TFBS ranged from 8.3% (CEBPB
in K562 cell line) to 67.7% (CTCF in GM12801 cell line). The median
percentage of the ancestral TFBS is only 18.5%. In other words, a sizeable
fraction of binding sites in humans is estimated to have recent origins after the
human-mouse split. For instance, human-specific TFBS (TFBS only present
in the human genome) ranged from 1.14% (CTCF ChIP-seq in GM12801
cell line) to 13.3% (ZNF263 ChIP-seq in K562 cell line). The fraction of
human binding sites that are unique to hominids but are not human-specific,
ranges from 3.4% (HSF1 ChIP-seq in HepG2) to 26.7% (BHLHE40 ChIP-
seq in HepG2). Figure 2.5 shows the percentage of TFBS with branch-
of-origin on different internal branches in the vertebrate phylogenetic tree.
Interestingly, significant proportions of ZNF274 binding sites are extremely
conserved where, on average, 12.2% TFBS originated from the human-fish
ancestor across seven samples. The previous study showed that ZNF274
binds to ZNF-encoding exons of ZNF proteins (Frietze et al., 2010). Indeed,
we found that 72.1% of ZNF274 binding sites that we predicted were located
at gene exons, which can explain why a significant fraction of ZNF274 binding
sites is ancestral. All the predictions of the lineage-specific TFBS can be
viewed on the UCSC Genome Browser. For example, Figure 2.6 shows
an example of the hominid-specific TFBS. This binding site appeared in
the human-orangutan last common ancestor because of a mutation in an
important position of the motif according to the multiple sequence alignment.
Even though ANTICE does not use the column-by-column information
across MSA, we observed a positive correlation between the percentages of
ancestral TFBS and the sequence constraints as indicated by the phyloP
score for TFBS across 355 samples as shown in Figure 2.7. Linear regression
confirmed that they were highly correlated with the R-squared value of 0.899.
TF binds to DNA in a highly sequence-specific manner because amino acids of
TF can recognize adjacent nucleotides in 3D as revealed by X-ray and NMR
structures studies (Pabo and Sauer, 1992). The potential (contact intensity)
of residue-nucleotide interaction determines the specificity of nucleotides at
each position of the motif, which is usually measured by information content
(IC) (D’haeseleer, 2006). Previous studies showed that base pairs having high
IC have fewer mutations and thus were more conserved than base pairs with
low IC (Moses et al., 2003; Mirny and Gelfand, 2002). Therefore, a motif
with high IC might be more ancestral than motifs with low IC. To test this
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hypothesis, we plotted the motif IC (normalized by motif length) against
the percentage of the ancestral TFBS for each motif. Unexpectedly, we
found that there is almost zero correlation between them as shown in Figure
2.8(A). At the same time, long motifs seem to have a higher percentage of the
ancestral TFBS compared with short motifs (Figure 2.8(B)). For example,
the median ancestral TFBS percentage is 18% for motifs of 8bp compared
with 35% for motifs of 15bp (P value < 10−5) although the discrepancy
is unclear. Overall, it seems that sequence constraints in binding sites are
associated with binding site conservation while motif degeneracy has little
impact on TFBS evolution.
2.4.2 Determine functional preference of lineage-specific
TFBS
Young TFBS are farther away from the TSS
Cheng et al. (2014) reported that human promoters have a higher fraction
of the human-mouse conserved ChIP-seq peak as compared with the distal
enhancers, which suggests strong negative selections in the human promot-
ers. However, the genomic distribution preference for the lineage-specific
TFBS in the human genome remains unknown. We argued that the genome-
wide lineage-specific TFBS dataset we generated could answer this question.
We grouped the lineage-specific TFBS based on their estimated evolution-
ary histories into four groups: 1) TFBS that are only present in the human
(human-specific TFBS), 2) TFBS that originated after hominids with the
human-specific TFBS removed (hominid-specific TFBS), 3) TFBS that ap-
peared after the human-mouse split but before the last common ancestor
of the hominids (mid-specific TFBS), and 4) TFBS that originated before
the human-mouse last common ancestor (ancestral TFBS). Figure 2.9(A)
shows the observed versus expected fraction of lineage-specific TFBS in dif-
ferent genomic regions. Younger TFBS are enriched in the distal intergenic
regions or the downstream of the gene body and are depleted in the ex-
ons/promoters, which is shown by boxplots in Figure 2.9(A). For example,
for TFBS located at distal intergenic regions, the median of the log2 fold
change of the human-specific TFBS is 0.19, while the median log2 fold change
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for the ancestral TFBS is -0.27 comparing with human-specific TFBS (P
value < 10−13). In contrast, ancestral TFBS are more likely to be present in
exons than human-specific TFBS (P value < 10−16), hominid-specific TFBS
(P value < 10−16), and mid-specific TFBS (P value < 10−16). The fraction
of the ancestral TFBS dropped from 47% to 22% when the distance between
TFBS and the TSS increases from 0bp to 1000bp as shown in Figure 2.9(B).
These results indicate that the TFBS at gene promoters are under stronger
negative selections than the TFBS in other genomic regions. Cheng et al.
(2014) showed that CTCF ChIP-seq peak among 32 TF ChIP-seq data ex-
amined is an exception, which shows a high fraction of conserved occupancy
between the human and mouse in both promoters and distal intergenic re-
gions. Using the CTCF data we collected, we confirmed that the fraction
of the ancestral CTCF binding sites between the exons and the distal in-
tergenic regions is similar (P value < 0.0002). However, the human-specific
CTCF binding sites are more significantly enriched in the distal intergenic
regions than the ancestral CTCF binding sites (P value < 10−16), and the
ancestral CTCF binding sites are more significantly enriched in the exons
than human-specific binding sites (P value < 10−14). Most CTCF bindings
sites located at distal intergenic regions are involved in insulator functions
and also work as the anchor points for the formations of chromatin loops. It
is interesting to explore whether these human-specific CTCF binding sites
at the distal intergenic regions are related to human-specific chromatin loop
formation.
Young TFBS are more tissue-specific
We proposed that the TFBSs bound by TFs in multiple tissues would be
under strong negative selections, and thus more likely to be conserved. To
test this hypothesis, we compiled DNase-I hypersensitive sites (DHS) across
53 normal cell lines/types available in the ENCODE project. We assumed
that if a TFBS is located in a DHS from tissue X, then this TFBS is functional
(bound by the TF) in this tissue. We formulated a tissue specific index (TSI)
based on the Shannon entropy to quantify the accessibility of a TFBS across
multiple tissues. Ideally, the TSI of a TFBS equals zero if that TFBS is
functional in every tissue type, and the TSI of that TFBS equals one if
that TFBS is only active in one tissue type. Remarkably, we observed a
26
continuous drop of the fraction of the ancestral CTCF binding sites in K562
as the TSI value increases (illustrated on the right side of Figure 2.10).
Here, we grouped TFBS TSI values into deciles according to their TSI values
to calculate the fraction of the ancestral TFBS. Specifically, the fraction
of the ancestral TFBS is 69% for the first TSI decile whereas that fraction
dropped to only 7% in the last decile. Concurrently, the combined fraction of
the human- and hominid-specific TFBS increased from 5% to 36%. Results
using the entire lineage-specific TFBS dataset showed similar patterns (see
the heatmap in Figure 2.10). This suggested that this association is not
biased toward a specific type of TFBS but is rather a general trend for the
overall human TFBS.
Young TFBS are more susceptible to mutations
In our previous analysis (Yokoyama et al., 2014), we found that the fraction
of the human-specific TFBS containing common SNPs is approximately 6%,
which is much higher than ancestral TFBS (less than 2%). In this study,
we explored this phenomenon using more ChIP-seq data. To make an accu-
rate comparison, we also improved our method by correcting the bias from
the background mutation rate. Briefly, the fraction of the TFBS containing
common SNPs was normalized using the background SNP density estimated
from the flanking regions (+/-100bp) of TFBS. Figure 2.11 shows the log2
fold change of the observed versus the expected fraction of the TFBS con-
taining common SNPs. Interestingly, common SNPs were only enriched in
human-specific TFBS, with the median of the fold change being between
1.31 and 1.75, depending on the genomic locations of TFBS. The fraction of
the hominid-specific or mid-specific TFBS containing SNPs is slightly lower
than expected with the median of the fold change being between 0.77 and
1.0. In addition, common SNPs are depleted twice as much in ancestral
TFBS as the flanking regions, indicating purifying selections in the ancestral
TFBS. The enrichment of SNPs in the human-specific TFBS suggested that
human-specific TFBS might be not shared across the human populations
and might obtain the potential for lineage-specific adaption or positive se-
lection. Indeed, using polymorphism data (Sethupathy et al., 2008) showed
that primate-specific and especially human-specific binding sites are evolving
under positive selection. We also tested whether mutation types can influ-
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ence the enrichment of the common SNPs. For six mutation types, mutation
rates (the number of common SNPs divided by the number of bases exam-
ined) elevated only at the human-specific TFBS, whereas the mutation rate
decreased at the ancestral TFBS as shown in Figure 2.12. Therefore, the
enrichment of common SNPs in young TFBS is not biased against a specific
mutation type.
Recently, (Perera et al., 2016a; Sabarinathan et al., 2016) observed an ele-
vated somatic mutation rate at active regulatory elements versus its flanking
regions in patients with melanoma. According to their conclusion, transcrip-
tion factors (TF) binding to the DNA can suppress the activity of nucleotide
excision repair (NER). This explains the accumulations of the mutations at
the TF binding sites. Based our observations, young TFBS are more tissue-
specific, which suggests that young TFBS are less frequently bound by TFs
than the ancestral TFBS through the cellular differentiation process. In ad-
dition, ancestral TFBS compared with young TFBS resemble the consensus
motif better as shown in Figure 2.13. Moreover, germline mutations en-
riched in the young TFBS can destroy the binding sites, limiting the potential
of TF binding to the motif. Therefore, we hypothesized that we should see
a higher mutation rate ratio at the ancestral TFBS than the young TFBS in
melanoma. Figure 2.14 shows the ratio of the mutation rate between TFBS
and the +/-250bp flanking regions. Indeed, the mutation rate ratio is the
lowest at the human-specific TFBS. We also found that most of the increment
of mutation rate comes from the functional CTCF binding sites in melanoma.
Here, we used the DHS from the human melanocyte to identify functional
TFBS in patients with melanoma. Specifically, the mutation rate ratio in
the ancestral TFBS showed a 5.5-fold increase for TFBS in the enhancers,
2.2-fold increase for the TFBS in the promoters, and a 2.8-fold increase for
the TFBS in other regions compared with the human-specific TFBS. As a
comparison, the mutation rate ratio only increased from 0.83 to 1.42 in the
non-functional CTCF binding sites (TFBS outside the melanocyte-specific
DHS regions). For the TFBS other than the CTCF binding sites, the mu-
tation rate ratio increased for the mid-specific TFBS compared with the
human-specific TFBS. However, the mutation rate ratio slightly dropped at
the ancestral binding sites. The negative selections toward the ancestral
TFBS might explain this reduction. However, why CTCF is so unusual com-
pared with other TFBSs is still unanswered.
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2.4.3 TFBS expansion can be driven by transposable elements
TEs are a significant source of the novel regulatory elements in the human
genome. Bourque et al. (2008); Schmidt et al. (2012); Sundaram et al. (2017)
previously demonstrated that a large fraction of the mammalian TFBS is
driven by expansions of transposable elements. However, the lack of species-
specific ChIP-seq datasets has restricted these studies in only a few TFs and
across a limited number of species. To fill this gap, we globally examined the
enrichment of TEs in lineage-specific TFBS. The heatmap in the Figure 2.15
shows the identified enrichment of TE families in different types of lineage-
specific TFBS. In general, ancestral TFBSs were less likely to be enriched for
the TEs compared with the young TFBS. For example, only 10% of the ances-
tral NFYA/B binding sites were enriched for the TEs compared with 30% for
the human-specific TFBS, 33% for the hominid-specific TFBS, and 23% for
the mid-specific TFBS. The high enrichment of the TEs in NFYA/B binding
sites is also consistent with the previous observation that approximately a
third of the NF-Y loci overlap with ERV1 (mainly LTR12, MLT1) in human
tumor cell lines (Fleming et al., 2013). Interestingly, among the enriched TE
families, ERV1 showed the strongest enrichment in NFYA/B binding sites
(P value <10−50) at TFBS with different a branch-of-origin. In addition to
the cases like NFYA/B, where a single TE family continuously expands the
collections of binding sites, we also observed many cases where distinct TEs
are likely to propagate along specific branches of the phylogeny. For exam-
ple, hominid-specific GATA1 binding sites were associated more with ERV1
than human-specific and mid-specific binding sites. GATA1 binding sites
with the branch-of-origin of primates exhibited enrichment of MIR. More-
over, hominid-specific CTCF binding sites were enriched for EVRK elements
while CTCF binding sites originated from primates were enriched for EVRL
elements. This is consistent with the previous analysis (Schmidt et al., 2012)
based on CTCF ChIP-seq across six species. Overall, transposable elements
can explain the formation of a significant fraction of the human TFBS. Here,
we believe that the lineage-specific TFBS resources might be helpful in pre-
dicting and prioritizing lineage-specific TFBS expansions by TEs for those
TFs with limited ChIP-seq data.
29
2.5 Methods
2.5.1 de novo search for motifs under ChIP-seq peak
We chose to identify primary and secondary motifs enriched in each ChIP-seq
dataset by custom pipeline. We did not obtain motifs from the available motif
database because motifs in the public database are often collected from var-
ious sources with different qualities. In addition, many TFs have secondary
motifs which might not be documented in the public database (Cheng et al.,
2014). Therefore, our strategy is that we firstly de novo searched for motifs
under ChIP-seq peaks. Then we used the public motif database to select
primary motifs from de novo identified motifs. The input files were 680 uni-
formly processed ChIP-seq peak files generated by the ENCODE Analysis
Working Group. Specifically, the procedures we used to identify putative
motifs with high confidence for each ChIP-seq data is following. Firstly,
peaks from each dataset were firstly shrunk to 200bp-long regions centered
on the peak summit. Five sets of 500 peaks were randomly sampled from the
top 25% peaks based on peak scores reported by the peak calling software.
In case there the peak number is below 2500, top 500 peaks were be used.
Then, we used MEME-ChIP to discover motifs from sampled peaks and the
top five scored motifs were selected for next step. We further selected motifs
discovered in all five sampled peaks. Lastly, motif candidates of each ChIP-
seq dataset were compared with the CIS-BP database (the largest species-
specific motif database). We divided motifs discovered from one dataset into
two groups, primary motifs that are matched well with known motifs for this
TF X in the database and secondary motifs that are matched with known
motifs from TFs other than TF X. Motifs that do not match any known
motifs in CIS-BP were removed.
2.5.2 Annotation of lineage-specific TFBS with functional
genomic annotation
To explore the enrichment of TFBS over different genomic regions, we cat-
egorized TFBS into promoters (located at the upstream 3kb of the TSS),
exons, introns, downstream (downstream 3kb of TSS), and distal intergenic
regions. Enrichment of lineage-specific TFBS under different genomic regions
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was calculated as a ratio between the observed and expected fraction of the
number of TFBS overlapped with genomic annotation.
TFBS tissue usages were estimated using open chromatin data as a proxy.
We came up with tissue specificity index (TSI) to measure the pleiotropic
effect of TFBS, where TSI was defined as:
TSI = 1−
∑N
t=1 pt × logx(pt)
log2N
(2.12)
, in which N is the number of tissues, and pt equals to 0 if a TFBS does not
overlap with DHS from tissue t or pt equals to 1/N if TFBS is located within
a DHS from tissue t.
Common SNPs were downloaded from the UCSC Genome Browser. The
expected fraction of TFBS containing common SNPs was calculated as the
product of N and p, in which N is the number of TFBS, and p is the prob-
ability that an SNP is located at TFBS. p was computed as:
p = 1− (1− b)L (2.13)
, where b is the background mutation rate (per bp) of TFBS flanking regions,
and (1 − b)L indicates the probability of no SNP is found in a TFBS with
length L. .
2.6 Figures and Tables
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Figure 2.1: The workflow of ANTICE. (A) Input and output of ANTICE.
Red boxes are sample-dependent input. Dark green boxes show the sample-
independent input. Light green box contains the intermediate results, and
blue box is the output of ANTICE. (B) The schematic diagram explains how
the birth-death model predicts lineage-specific using the intermediate results.
On the right is the number of TFBS in each extant species within ChIP-seq
peak. The prediction of birth-death model would be the predicted branch-
of-origin of TFBS shown as highlighted internal branches in the phylogenetic
tree.
Figure 2.2: ANTICE has higher accuracy than BOO on benchmark data
used in the BOO paper (Yokoyama et al., 2014)
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Figure 2.3: The performance of ANTICE is not sensitiv to motif scan thresh-
old. Left: ANTICE. Right: GREP score. The x-axis is the motif searching
cutoff. F1 scores are shown on the y-axis.
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Figure 2.4: Primary motifs identified in the human ENCODE ChIP-seq data
are clustered based on the motif similarity. The heatmap shows the similarity
(correlation coefficient) between motifs. Several motifs clusters derived from
single TF is marked with details of CEBPE cluster shown on the right.
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Figure 2.5: Heatmap shows the distribution of predicted lineage-specific
TFBS for 393 primary motifs. Columns represent motifs. Row indicates
predicted TFBS branch-of-origin regarding the internal branch in the 46-
way vertebrate phylogenetic tree. Colors show the fraction of TFBS with a
certain branch-of-origin among total TFBS for each data set.
Figure 2.6: A UCSC Genome Browser screenshot shows an example of pre-
dicted lineage-specific TFBS near FHOD1 gene. Predicted TFBS track con-
tains all the lineage-specific TFBS in that region. Binding sites with dark
color are more ancestral than TFBSs with the light color. A zoom-in view of
a hominid-specific TFBS identified from ChIP-seq data of five TFs is shown
on the bottom. ENCODE ChIP-seq peak track shows ChIP-seq peaks from
different cell types and labs with rectangle box indicating peak summit. Or-
ange box highlighted within multiple sequence alignment shows E-box motif
shared by the primary motif of five TFs. Note that orthologous E-box motif
shared from human to orangutan are mutated in other species.
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Figure 2.7: Sequence conservation at TFBS correlates well with the predicted
TFBS branch-of-origin. Scatter plot shows the fraction of Ancestral TFBS
(x-axis) and the median phyloP score (y-axis) for each motif data set. There
is a strong linear relationship between Ancestral TFBS fraction and median
phyloP score under TFBS.
Figure 2.8: Correlations of the motif degeneracy and the motif length with
the fraction of Ancestral TFBS. (A) Scatter plot shows the relationship be-
tween motif Information Content (IC) and the fraction of Ancestral TFBS
predicted for that motif. (B) Correlation between Ancestral TFBSS fraction
over motif length.
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Figure 2.9: Young TFBS are depleted in the promoter regions. Boxplot
shows the log2 fold change of observed vs. expected fraction of overlap with
five genomic locations for lineage-specific TFBS. Lineage-specific TFBS were
grouped into human-specific TFBS, hominid-specific TFBS (nor including
human-specific TFBS), ancestor TFBS (with the branch of origin before hu-
man mouse last common ancestor) and mid-specific TFBS (primate-specific
but not hominid-specific). (B) Stacked barplot shows the fraction of four
lineage-specific TFBS groups along +-500bp region around TSS (transcrip-
tion start site) with step size 20bp.
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Figure 2.10: Young TFBSs are more tissue specific. (A) For each primary
motif (rows), TFBS were stratified by tissue specific index (TSI) of TFBS
into deciles (columns). Colors are the percentage of Ancestral TFBS scaling
into z-score in each row. Violin plot on the top shows z-score distribution
across deciles. (B) Stacked bar plot shows the fraction of lineage-specific
TFBS in one motif results. The x-axis is 10 decile groups based on percentile
distribution of TSI for CTCF TFBS in K562 cell line. Y-axis shows the
fraction of four lineage-specific TFBS groups in TSI decile.
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Figure 2.11: Common SNP are enriched in the human-specific TFBSs. Box-
plot shows the log2 fold change of observed vs. expected fraction of TFBS
contained human UCSC Common SNP for four lineage-specific TFBS groups.
Different panels show TFBS locating at different genomic regions.
Table 2.1: Performance comparison between ANTICE, GERP, and PhyloP
using benchmark data for different linage-specific TFBS. Values in each cell
represent AUROC. Different cutoff were used for split ChIP-seq peak regions
into lineage-specific or conserved based on the average GEPR or PhyloP score
int the window of 200bp centered on peak summit. The best method in each
benchmarks is shown in bold.
Benchmark Methods CTCF CEBPA FOXA1 HNF4A HNF6
Human-Rhesus
ANTICE 0.782 0.838 0.828 0.815 0.838
GERP 0.509 0.633 0.654 0.633 0.624
phyloP 0.591 0.714 0.698 0.689 0.684
Human-Mouse
ANTICE 0.841 0.864 0.854 0.843 0.875
GERP 0.545 0.798 0.806 0.733 0.859
phyloP 0.622 0.823 0.827 0.769 0.875
Human-Rat
ANTICE 0.819 0.885 0.860 0.858 0.865
GERP 0.534 0.783 0.811 0.763 0.854
phyloP 0.610 0.810 0.828 0.793 0.868
Human-Dog
ANTICE 0.853 0.880 0.868 0.881 0.841
GERP 0.551 0.810 0.820 0.781 0.833
phyloP 0.627 0.832 0.839 0.810 0.849
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Figure 2.12: Mutation rate elevates only at human-specific TFBS for six
mutations types. Mutation rates (Common SNP) in +/- 500bp from TFBS
center is shown for four lineage-specific TFBS groups across six mutation
types. human-specific TFBS have significant high mutation rate at TFBS
loci while mutation rate drops for Ancestral TFBS.
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Figure 2.13: Ancestral binding sites better resemble the consensus motif than
the lineage-specific TFBS. Boxplots compare the percentile distributions of
the log-likelihood scores across lineage-specific TFBS. Top and bottom edge
of the box represent the first and the third quartile. Median is shown as the
line inside the box. Whiskers extend from the edge of the box no further
than 1.5 times inter-quartile ranges (IQR).
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Figure 2.14: The enrichment of somatic mutations at active TFBS in
Melanoma is stronger at the ancestral binding sites than the young bind-
ing sites. Barplot shows the mutation rate ratio (Y-axis) between the TFBS
and its flanking regions at different regions (X-axis). TFBS from all the TFs
examined is shown on the top panel with the label ’All TFs’. Panel with
label ’CTCF’ contains TFBS only from CTCF or CTCFL ChIP-seq. The
bottom panel shows the mutation rate ratio for TFBS other than CTCF or
CTCFL.
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Figure 2.15: Specific TE family enriched in different lineage-specific TFBS.
Heatmap shows the enrichment (P value) of each TE family in lineage-specific
TFBS. Each TE family has four columns repsenting human-specific TFBS,




LANDSCAPE OF UV INDUCED
MUTAGENESIS AT REGULATORY
ELEMENTS IS STRONGLY INFLUENCED
BY NEARBY GENOMIC CONTEXT
3.1 Background
Somatic mutations, which are the hallmarks of cancer development and pro-
gression (Hanahan and Weinberg, 2000), are accumulated due to the gradual
loss of balance between DNA damage and DNA repair (Jeggo et al., 2016).
Systematic sequencing of cancer genomes reveals that somatic mutations are
not constant across the human genome (Hodgkinson et al., 2012; Lee et al.,
2010; Puente et al., 2011; Pleasance et al., 2010a,b; Lawrence et al., 2013;
Hodgkinson and Eyre-Walker, 2011; Chapman et al., 2011). Variations of
germline mutations along the human genome have also been confirmed by
comparative genomic and population genetics approaches (Ellegren et al.,
2003; Wolfe et al., 1989). With more and more functional genomic data
available regarding the human genome, particularly from the large consor-
tia such as the ENCODE project and the Roadmap Epigenomics project
(Roadmap project), an integrative analysis that combines functional genomic
data with cancer mutation data is needed to understand the potential cause
of somatic mutation heterogeneity. At the megabase-scale, mutation rates
are correlated with chromatin states, such as chromatin openness and replica-
tion timing (Makova and Hardison, 2015; Polak et al., 2014; Liu et al., 2013;
Schuster-Böckler and Lehner, 2012). Schuster-Böckler and Lehner (2012)
found that the heterogeneity of mutation rate along the genome is strongly
associated with chromatin organization featured by histone modifications,
such as H3K9me3, which alone can account for 40% of mutation rate varia-
tions. Polak et al. (2015b) revealed that mutation rate has a negative correla-
tion with chromatin accessibility and epigenetic state of tumor cell-of-origin,
which in conjunction with replication timing, dictate 74%-86% of the muta-
tion rate variations. They argued that the decreased mutation rate on open
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chromatin is likely due to the enhanced ability of DNA repair machinery to
access and repair DNA damage. However, at the nucleotide-scale, Perera
et al. (2016a); Sabarinathan et al. (2016) recently found that transcription
factors (TF) binding to the DNA could suppress the activity of nucleotide
excision repair (NER), resulting in elevated mutation rate at active TFBS
or DNase I hypersensitive sites (DHS) within active transcription initiation
sites. Therefore, while open chromatin regions are associated with decreased
mutation rates, the local mutation rate at TFBS within DHS can still be high
because DNA-bound TFs hinder DNA repair. With an increasing number
of functional genomic resources, additional links between mutation rate and
cellular processes have yet to be discovered.
Despite providing novel insights into the interplay between TF binding,
NER, and mutation occurrence, studies from Perera et al. (2016a) and Sabar-
inathan et al. (2016) drew their conclusions by primarily focusing on a few
cis-regulatory regions with limited complexity, such as promoter DHS versus
enhancer DHS, or proximal TFBS versus distal TFBS. However, whether the
genomic context of regulatory elements (i.e., epigenetic state and sequence
composition) is associated with the mutation rate at regulatory elements and
the extent to which these two factors are correlated remains unclear. Compre-
hensive assessment of various genomic features that may correlate with local
mutation rate around DHS is still lacking. There exists some evidence sug-
gesting that the observed mutation rate at regulatory elements may correlate
with the chromatin context of regulatory elements. First, previous studies
have shown that nucleosome positioning as well as histone surface-mediated
DNA-histone interaction could influence DNA damage rates (Pfeifer, 1997;
Mao et al., 2016). Moreover, Adar et al. (2016) showed that different ge-
nomic regions have distinctive DNA repair rates. They found that damage
in open chromatin states based on chromHMM predictions is repaired early
in both global and transcription-coupled NER, suggesting the ability of the
local chromatin context to influence repair rates of damage. Lastly, as shown
by Perera et al. (2016a) and Sabarinathan et al. (2016), flanking regions of
active TFBS of DHS exhibit DNA repair activity similar to that of the center
of TFBS or DHS, but the latter has a much lower mutation rate (Figure
3.1). Their observation implies that mutation rate variations may depend
on other unknown factors such as the genetic context of regulatory elements.
Therefore, this evidence prompted us to determine, aside from NER, whether
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and to what extent local genomic context together with TF binding could
modulate local mutation rates in regulatory elements.
In this chapter, we sought to answer the aforementioned question by care-
fully examining the associations between the genomic context of regulatory
elements and the variations of somatic mutation rate at regulatory elements.
Specifically, we screened over 19 million somatic mutations (only consider
single nucleotide substitutions) in 183 patients with melanoma collected by
the International Cancer Genome Consortium (ICGC). Functional genomic
data from tumor cell-of-origin were also collected from public resources. We
determined the changes of the mutation rate ratio between the center of DHS
and the flanking regions of DHS with alterations of a single genomic feature,
pairwise combinations of genomic features, and entire genomic features as a
whole (details in Section 3.2-3.4). We found that local genomic context
(such as such as H3K4me3 histone modification, GC content, and distance
to downstream TSS) significantly modulate mutation rate surrounding DHS,
which cannot be solely explained by NER variations (details in Section 3.5).
Similar analysis framework employed on TFBS confirmed the observed asso-
ciations (details in Section 3.6). In addition, we noticed that local mutation
rate varies for different TFs. TFs with CGGAAT motif pattern such as ETS1
show much higher mutation rate ratio than other TFs suggesting a potential
positive selection of regulatory elements in melanoma. Also, while the mu-
tation rate elevates at the majority of promoter TFBSs, the mutation rate
elevates only at CTCF/cohesin binding sites but not other TFBS in distal
intergenic regions (details in Section 3.7). In summary, our study reveals
that somatic mutation occurrences at regulatory regions are dependent on
the genomic context of regulatory regions.
3.2 Mutation variations at DHS are genomic-context
dependent
We explored how the mutation rate profiles around DHS are associated with
the genomic context of DHS in the entire human genome. The genomic con-
text of regulatory regions was determined by various functional genomic data
collected from public resources (see Table 3.1). In the simplest scenario, we
performed a univariate analysis between the mutation rates and the quantiles
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of those 52 genomic features compiled from public datasets (see Section 3.9
for the sources for the datasets and Figure 3.2 for the overall workflow). We
converted actual feature values to quantiles because quantiles are invariant
to monotone transformation and not sensitive to extreme values (Li et al.,
2014; Coles et al., 1999).
For each genomic feature, such as H3K4me3 signal, we firstly stratified
genome-wide DHS into 20 equally sized groups (termed 20-quantiles or vig-
intiles) based on the H3K4me3 signal under DHS center region (+/-25bp from
DHS center, named “DHS-center”). The mutation rate ratios (normalized
by GC content) between DHS-center and 1kp flanking regions of each side
(named “DHS-flank”) were then plotted as a heatmap with columns showing
vigintiles and rows showing genomic features as in Figure 3.3(A). A chi-
square test of the null hypothesis that mutation rate is the same for DHS-
center and DHS-flank produced a P value for each stratum. Surprisingly,
we found that the mutation rates differ dramatically between DHS-center
and DHS-flank across vigintiles for the majority of features we examined
(Figure 3.3(A) and Figure 3.4). For example, the mutation rate between
DHS-center and DHS-flank (named DHS C/F ratio) is 0.859 (P value =
10−2) for the vigintile with the lowest DNase I hypersensitivity, while the
DHS C/F ratio increases to 2.29 (P value < 10−16) for the vigintile with the
highest DNase I hypersensitivity as shown in Figure 3.3(B) and Figure
3.5.
Clustering the 52 genomic features based on DHS C/F ratios across vig-
intiles revealed that two types of features had either a positive or negative
association trend (see the dendrogram of heatmap in Figure 3.3(A)). In-
terestingly, no genomic features showed non-monotonic trends. Next, we
calculated Pearson correlation coefficients (PCC) between DHS C/F ratios
and average genomic feature values of vigintiles to quantitatively measure
their monotonic relationship. Genomic features that are positively correlated
with the DHS C/F ratio include DNase I hypersensitivity (PCC: 0.986), GC
content (PCC: 0.802), H3K4me3 signal (PCC: 0.507), and several sequence
features such as CCG and GCG frequency (the fraction of a specific 3-mer
among the total number of 3-mer within DHS-center regions). Conversely,
genomic features such as the distance to the closest downstream TSS (PCC:
-0.360), H3K4me1 signal (PCC: -0.952), and ACA 3-mer frequency (PCC:
-0.971) are negatively correlated with DHS C/F ratios. We confirmed that
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the observed associations are not biased towards the arbitrary assignment
of DHS by randomly permuting DHS into 20 equal-sized groups 1000 times.
The observed PCC values dramatically deviated from the PCC value distri-
bution calculated from permutations. In addition, the sequence context of
DHS-center strongly affected the DHS C/F ratio. Notably, if we ranked 32
3-mers according to the difference between the maximum and minimum of
DHS C/F ratios across vigintiles, NCG (N is a nucleotide from A, C, G, T)
has the highest numeric range of mutation rate ratios, followed by NCC. Fre-
quencies of 3-mers with NCG or NCC pattern are positively correlated with
DHS C/F ratio, as shown in Figure 3.3(A)) and Figure 3.4. However,
the high mutation rates associated with high NCG or NCC frequency are
not due to the relative number of NCG and NCC patterns between DHS-
center and DHS-flank. The increased mutation rate at DHS with the high
frequency of NCG and NCC might be related to methylation of DNA, as
previous literature has shown that methylation of dipyrimidine sites can en-
hance CPD formation (Drouin and Therrien, 1997; Tommasi et al., 1997;
You et al., 2000). It has been shown that UV-B induces CPD at methylated
CG sites much more frequently than UV-C does Drouin and Therrien (1997).
We noted that these types of association rules were not described in recently
published genome-wide UV-C-induced damage dataset (Hu et al., 2017). In
summary, the surprisingly ubiquitous associations between mutation rate ra-
tios of DHS and the genomic context at DHS provide the initial support for
the potential interplay between genomic context and DNA damage/repair at
DHS.
To test whether the observed associations were sensitive to the parame-
ters we used, we repeated the analyses using different parameter settings.
The first parameter we explored is the size of the DHS-center region. Fig-
ure 3.6 shows the pairwise comparison of mutation rate ratios when the
size of the DHS-center region increased from +/-15bp to +/-75 bp. The
first clear observation from Figure 3.6 is that the DHS C/F ratios are ro-
bust against DHS-center size, as Pearson’s correlation coefficient of pairwise
comparisons of the mutation rate ratio using different DHS-center sizes is
at least 0.83, and the median is 0.95. Next, we tested whether the associa-
tion patterns are biased towards a subset of patients. Figure 3.7 shows the
PCC for the DHS C/F ratios using mutation data from individual patients.
We observed similar trends across 52 genomic features for the majority of
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patients. Therefore, the ubiquitous association trends we detected do not
seem to be influenced by a single patient but rather are common phenomena
shared by patients with melanoma cancer. However, we did observe that
those trends are more pronounced in the patients with high mutation load
and the patients with a high fraction of C to T mutations (Figure 3.8). C to
T mutations have been widely recognized as the primary mutation signature
induced by UV radiation, the most important environmental risk factor for
melanoma (Alexandrov et al., 2013). We then asked whether different mu-
tation substitution classes share similar association patterns. To answer this
question, we applied our analysis framework to six types of mutation substi-
tution datasets. Surprisingly, only C to T mutations could produce consistent
association trends (see Figure 3.9). In addition, almost all monotonic rela-
tionships disappeared when mutation data extracted from 36 patients with
non-UV related melanoma was used (Figure 3.10(A-B)). Interestingly, at
the megabase-scale, genomic features have the same patterns with mutation
count for all of the six types of mutation datasets (Figure 3.10(C)). How-
ever, the correlation between the genomic features and mutations was more
significant for C to T mutations than other mutation types. In summary,
we observed that at the nucleotide-scale, monotonic associations between
genomic features and the DHS C/F ratios only existed in the C to T muta-
tion in patients with UV-related melanoma but not in patients with non-UV
related melanoma. Together, these observations suggest that genomic fea-
tures can influence the process of C to T mutations in melanoma at both the
megabase and nucleotide scales.
Besides continuous genomic features, we also explored categorical genomic
features under DHS, such as chromatin states predicted by ChromHMM
Ernst and Kellis (2012). Consistent with results of H3K4me3 signal and
the nearest distance to the TSS, mutation rate was elevated in DHS-center
marked as promoter regions based on predictions from ChromHMM (DHS
in 1 TssA, fold change 2.51, P value <10−16)). We got similar conclusion
when promoters were defined as the upstream 3kb regions of the TSS (fold
change 2.24, P value <10−16) as shown in Figure 3.3(C). Interestingly,
DHS-center regions containing CTCF binding site had 1.62x higher (P value
<10−16) mutation rate than DHS-flank while DHS-center without CTCF
binding site had lower mutation rate (fold change 0.894, P value <10−16)
than DHS-flank (Figure 3.3(C)). Results from categorical genomic features
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once more confirmed that mutation rate ratios near DHS were correlated
with the genomic context of DHS.
3.3 Genomic features jointly associate with mutation
rate ratio of DHS
Features themselves can be correlated; for example, regions close to the TSS
tend to have high GC content (Khuu et al., 2007; Koudritsky and Domany,
2008), and early replicated regions are associated with high GC content (De-
schavanne and Filipski, 1995). However, from the univariate analysis, it
remains unclear whether and to what extent the correlation between repli-
cation timing and mutation rate ratio is associated with GC content varia-
tions. One way to solve this question is to determine the contribution of a
genomic feature A (e.g., replication timing) to the observed mutation varia-
tions while controlling the effect from a confounding genomic feature B (e.g.,
GC content). To do that, we extended the univariate analysis by stratify-
ing DHS into 20 × 20 groups based on pairwise combinations of vigintiles
from two genomic features (see Section 3.9). We then calculated the par-
tial correlation coefficient between feature A and the mutation rate ratio,
meanwhile controlling the effect of cofactor feature B. Figure 3.11(A-
B) shows the comparison of correlation coefficients from univariate analysis
and the partial correlation coefficient. In general, the trends of correlation
(positive/negative) are preserved after removal of the confounding genomic
features (P value <10−16), although the partial correlation coefficient is of-
ten weaker than the original correlation coefficient (Figure 3.11(B). The
difference between the univariate correlation coefficient and partial correla-
tion coefficient varies for different genomic features. For example, the partial
correlation coefficient between GCC 3-mer frequency and DNase I signal is
0.58, but the value drops to -0.02 for GCC versus CCG 3-mer frequency. We
argue that if a genomic feature (co-factor) always leads to a large decrease
of the correlation trend with other genomic features, this genomic feature is
more likely to affect other genomic features in regard to mutation variations.
In other words, other genome features depend on this genomic feature.
Therefore, we named the difference between the univariate correlation and
the partial correlation coefficient the feature dependence index (FeDI) and
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used it to quantitatively measure the importance of features. FeDI measures
the dependence of feature A on feature B in terms of the correlations between
feature values and mutation rate ratio (Figure 3.12(A)). For example, the
positive trend between the H3K27ac signal (feature A) and the DHS C/F
mutation rate ratio revealed in univariate analysis disappears under strat-
ification of the GC content (feature B) (Figure 3.12(B)). In this case,
FeDI(A,B) is high. In contrast, H3K27ac (feature A) and ACC 3-mer fre-
quency (feature B) display an additive relationship (Figure 3.12(B)), which
yields a low FeDI(A,B). Therefore, if FeDI(X,B) is high for Feature X
toward feature B, then feature B should make a greater contribution to
mutation variations. Applying the FeDI metric to all of the pairwise com-
binations of genomic features, we found that H3K4me3 signal, GC content,
and the distance to the nearest downstream TSS are the top three features
on which other features rely (see the green boxes in Figure 3.12(A)).
Bivariate analysis of the genomic features can also provide some insight
into how combinations of genomic feature jointly modulate the DHS C/F
ratio. A recent study Perera et al. (2016b) demonstrated that mutation rate
was elevated at the promoter DHS but not at the enhancer DHS, implying a
binary division of DHS regarding mutation variations at DHS. In their paper,
promoter DHS was defined as the DHS overlapping with the H3K4me3 peaks
but not the H3K4me1 peaks, and enhancer DHS was the DHS overlapping
with the H3K4me1 peaks but not the H3K4me3 peaks. However, it is un-
known whether the DHS C/F ratio was correlated with H3K4me3 signal only,
or if the DHS C/F ratio was a function of the combination of H3K4me3 and
H3K4me1. Moreover, promoter DHS and enhancer DHS only represented
16.3% of the entire DHS they identified. We still do not know the landscape
of the DHS C/F ratio at the remaining DHS. To answer these questions, we
applied our integrated analysis framework to their DHS dataset (DHS peaks
were called using the same DNase-seq data as the Roadmap project with a
different pipeline). We firstly reproduced their observation on the promoter
DHS and the enhancer DHS (Figure 3.13(A-C)). Next, the nearly identical
trends between mutation rate ratio and 52 genomic features vigintiles were
revealed (Figure 3.13(D)), suggesting the associations between mutation
rate ratio and genomic features at DHS are not sensitive to the DHS peak
calling algorithm. If we stratified DHS using both the H3K4me3 signal and
the H3K4me1 signal, we were able to observe an additive pattern between
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those two marks regarding the mutation rate ratio (Figure 3.14). There-
fore, our results implied that the DHS C/F ratio discrepancy between the
promoter DHS and the enhancer DHS is more likely to be due to two ex-
treme cases from the combination of H3K4me1 and H3K4me3. If we consider
genome-wide DHS, mutation rate variations at DHS are dependent on both
H3K4me3 and H3K4me1 signal. This hypothesis is more convincing than
the binary division hypothesis as it can explain mutation variations in the
majority of DHS identified, especially the massive DHS belonging to neither
enhancer nor promoter.
3.4 Multivariate analysis—A random forest model to
predict mutation rate ratio at DHS
Bivariate study does not consider triple-wise interactions or even more com-
plex interactions between the genomic features. We further implemented
a random forest model to quantitatively model the DHS C/F ratio using
all the aforementioned genomic features (distance to the nearest upstream
TSS and distance to the nearest downstream or upstream of the nearest
TES were removed because these are highly correlated with distance to the
nearest downstream TSS). DHS were first clustered by k-means clustering
using the top principal components explaining 95% of the data variance, as
illustrated in Figure 3.15. We then trained a random forest model using
repeated five-fold cross-validation and reported performance on 25 test sets.
Remarkably, predictors (defined as the average genomic feature value in each
cluster) could account for up to 91% of the variance (based on R-squared
measurement of the 25 test set) of mutation rate ratios across DHS clusters.
Also, predictions were not biased against the number of clusters defined in
the k-means clustering, since the results derived from 800 clusters were com-
parable to the results we obtained when cluster numbers ranged from 200 to
1000. Note that none of the pairwise comparisons produced a P value < 0.05
based on the rank-sum test) (Figure 3.16).
Feature importance reported from the random forest model was consistent
over 25 test sets (Pearson’s correlation coefficient <0.906) as shown in Fig-
ure 3.17. On average, the top five essential features were the distance to
the nearest downstream TSS, GCG 3-mer frequency, CCG 3-mer frequency,
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DNase I hypersensitivity, and ACA 3-mer frequency. The results from the
random forest model were further validated using a recursive feature elim-
ination method to identify the minimal set of genomic features predictors.
As few as 4 to 11 features were sufficient to capture the variation derived
from the whole set of the genomic features (Figure 3.18). These results
confirmed that primary features from the bivariate analysis including GC
content, H3K4me3, and distance to the nearest TSS are highly associated
with mutation rate ratio at DHS even considering interactions with all other
features. We also demonstrated that we could build a robust model to pre-
dict mutation rate variations at DHS utilizing only the genomic features at
DHS.
3.5 Mutation variations at DHS cannot be fully
explained by NER activity
Thus far, we have discovered and validated the ubiquitous associations be-
tween the genomic features at DHS and the mutation variations at DHS.
However, the critical question remains regarding why these associations ex-
ist. One possibility is that the genomic context of DHS is the determinants
of the mutation rate variations at DHS. It is also possible that those ge-
nomic features directly modulate the NER activity around DHS, and the
latter indirectly affect the mutation rate ratio variations at DHS. To answer
this important question, we compared the trends of NER activity versus the
genomic features vigintiles at DHS-center and DHS-flank, respectively. We
calculated the Pearson’s correlation coefficient between the genomic features
values and the NER activity in DHS-center or DHS-flank across vigintiles.
Among 42 genomic features, only 2 (5%) for 6-4PP UV damage or 7 (16%)
for CPD damage showed reverse correlation in DHS-center compared with
DHS-flank,100kb, and 1Mb genomic bins (Figure 3.19). On the contrary,
applying the same strategy to the mutation rate demonstrated 27 (65%) out
of 42 features have completely reverse correlation in DHS-center versus the
trend in DHS-flank or genomic bins as illustrated by Figure 3.19. Although
we cannot rule out the possibility that genomic features may modulate NER
activity at DHS in tumor cells, our observations indeed highlighted the im-
portant roles of genomic features in shaping mutation rate variations in open
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chromatin regions. Decreased NER activity at the DHS center cannot fully
explain the ultra-high mutation rate at DHS with high GC content. Further
experiments on high-resolution genome-wide UV-induced DNA damage dis-
tributions will be helpful to understand how mutation rates change under
different genomic features.
3.6 Mutation rate ratio of TFBS under distinct
genomic features
The model suggested by (Perera et al., 2016a; Sabarinathan et al., 2016)
states that it is the binding of TFBS within DHS which prevents NER
machinery from accessing DNA. Our analysis of DHS led naturally to the
question of whether mutation rate ratios at TFBS within DHS also corre-
late with genomic features of TFBS. To answer this question, we compiled
genome-wide TF binding sites overlapping with melanoma DHS. We sepa-
rated TFBS into CTCF-like TFBS, including CTCF, CTCFL, RAD21, and
SMC3 binding sites, and “Other TFBS” since we have observed that the
DHS containing CTCF binding sites have higher mutation rate ratios than
the DHS without CTCF binding sites (Figure 3.20(A)). While mutation
rate ratio between TFBS and TFBS-flank (+/-1000bp from TFBS center)
were high across four kinds of CTCF-like TFBS (fold change ranges from 2.9
to 3.5), Other TFBS showed a broad distribution of mutation rate ratios,
ranging from 0.4 (SMARCC1) to 12 (NR2C2) as shown in Figure 3.20(B).
The wide range of mutation rate ratios was consistent with the previous
study, which discovered an uneven distribution of somatic mutations from
TCGA projects within TFBS (Kaiser et al., 2016; Melton et al., 2015).
We next sought to examine the association between mutation rate ratio
and genomic features by stratifying TFBS according to the genomic features
at TFBS into vigintiles. To make a fair comparison, we adopted the vigintile
definitions obtained from DHS, i.e., each stratum of TFBS vigintiles had the
feature value boundary identical to that of the corresponding DHS stratum.
In addition, we removed the genomic features related to DNA sequences com-
position, including GC content and 3-mer frequency since TFBS is generally
less than 30bp, which makes the 3-mer frequency too discrete to be informa-
tive. Heatmaps in Figure 3.20(C) show the comparison of the association
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trends between DHS and TFBS. In summary, of the 19 genomic features
examined, 17 (89.5%) of them had consistent trends in “Other TFBS” com-
pared with DHS, and the value dropped to 12 (63.1%) for CTCF-like TFBSs
as genomic features including DNase I hypersensitivity, H3K4me3 signal,
H3K27ac signal, H3K9me3 signal, and H3K4me1 signal exhibited opposite
trend. Even if we only use TFBS from TFs with low mutation rate ratios
(fold change < 1 based on Figure 3.20(A)), we still observed 17 out of 19
genomic features showing consistent trends compared with the DHS results
(Figure 3.21). Sung et al. (2014) and Melton et al. (2015) discovered CTCF
has a much longer residence time of binding to chromatin than other TFs,
which produces a weak DNase I hypersensitivity within CTCF binding sites
yet a strong DNase I hypersensitivity at the flanking regions of binding sites.
Gusmao et al. (2016) devised protection score to better characterize the bind-
ing dynamic of TF considering the cutting bias of DNase-seq, which in turn
conferred better prediction power of TF binding events in DHS. Therefore,
we argue that the opposite trend in CTCF-like TFBS may come from the
fact that the DNase I hypersensitivity (cleavage count per bp) suitable for
DHS analysis may not be a proper indicator of real CTCF accessibility to
DNA. To verify this idea, we applied three metrics (Neph et al., 2012; Gus-
mao et al., 2016; He et al., 2014) to measure the extent of chromatin being
protected by TFs, used them to stratify CTCF-like TFBS, and compared
the trend with the traditional DNase I hypersensitivity (cleavage count). All
three methods produced positive associations between CTCF accessibility
and mutation rate ratio, as shown in Figure 3.20(D). Therefore, analyses
from the active TFBS verified the associations between genomic features and
mutation rate ratios that we had learned from DHS.
To explore the impact of GC content on mutation rate ratio, we combined
binding sites from the same TF, calculated the GC content based on the entire
binding sites from one TF, and compared GC content with mutation rate
ratio for each TF. Surprisingly, we observed a positive correlation across both
CTCF-like TFBS and Other TFBS (Figure 3.22(A)), which is consistent
with results from DHS. Figure 3.22(B) shows the de novo motif identified
in +/-10bp around TFBS for TFs with the top five highest mutation rate
ratios. We noticed that TFs with a CGGAAT DNA binding motif have
much higher mutation rates than the TFBS of other TFs. In fact, removing
those TFBS (NR2C2, ELK4, GABPA, and IRF3) increased the Pearson’s
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correlation coefficient between GC content and mutation rate ratio from 0.26
to 0.35 Figure 3.22(B). The same analysis was applied to 3-mer and showed
that among 32 3-mers, 29 (91%) of them have identical trends in both DHS
and TFBS as shown in Figure 3.22(C). This observation suggests a novel
positive selection in melanoma progression.
3.7 Elevated mutation rate is only observed at CTCF
TFBS in distal intergenic region
According to our results, distal TFBS other than CTCF-like TFBS should
have lower mutation rates in TFBS than in TFBS flank. However, Sabar-
inathan et al. (2016) found a remarkably elevated mutation rate at distal
TFBS. Since CTCF-like TFBS have high mutation rate ratios both in proxi-
mal or distal to the TSS, we argued that the elevated mutation rate they ob-
served at distal TFBS could be biased towards CTCF-like TFBS. We plotted
mutation rate around TFBS center for CTCF-like TFBS and Other TFBS,
also considering different genomic regions (distal intergenic versus promoter).
We found that while two TFBS sets both showed elevated mutation rates for
TFBS in the promoters, only CTCF-like TFBS have increased mutation rates
in the distal intergenic regions, as shown in Figure 3.23. In fact, the muta-
tion rate of Other TFBS in distal intergenic regions was even slightly lower
than TFBS flanking regions. Additionally, we observed that mutation rates
at flanking regions of distal CTCF binding sites oscillate with a frequency like
that of the pattern of nucleosome occupancy. However, we did not see this
pattern for Other TFBS located at distal intergenic regions. In conclusion,
our results suggest that the observations on distal TFBS from Sabarinathan
et al. (2016) are not correct or at least not accurate. TFBS located at distal
intergenic regions should have lower mutation rates in TFBS as compared
with the TFBS flanking regions, consistent with our observation that dis-
tance to the nearest downstream TSS is inversely correlated with mutation
rate ratio at TFBS. However, CTCF is an exception, as it shows a high
mutation rate ratio at regions both proximal and distal to the TSS. Poulos
et al. (2016) recently showed that mutation rate at CTCF binding sites colo-
calized with cohesin binding sites was higher than CTCF binding sites not
colocalized with cohesin binding sites. However, the number of CTCF bind-
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ing sites used in that study was only one-fourth of that used in Sabarinathan
et al. (2016), which is also the same data set we used. Therefore, we need to
further examine the relationship between genomic features and mutations in
CTCF/cohesin binding sites and compare them with other TFBS.
3.8 Discussion
Our study provided the first comprehensive assessment of the variations of
mutation rate at DHS and TFBS under the different genomic context in
melanoma. Our results refined previous observations (Sabarinathan et al.,
2016; Perera et al., 2016a) and suggested that mutation rate ratio at regu-
latory elements correlated with genomic features of regulatory elements as
well. Perera et al. (2016a) revealed that high DNase I accessibility connects
with high mutation rate ratio in promoter DHS. Here, analyzing genome-
wide DHS, we identified that closeness to the TSS, high H3K4me3, high
GC content (including related GCG, CCG 3-mer frequency), and DNase I
hypersensitivity are primary genomic features related to high mutation rate
ratio. We also validated the importance of these genomic features using both
empirical and quantitative modeling. Additionally, CTCF-like TFs and TFs
with a CGGAAT motif pattern showed TF-specific mutation profiles, sug-
gesting more complex mechanisms of interplays between DNA damage and
repair.
Mutation rate heterogeneity is a common feature in cancer (Hanahan and
Weinberg, 2000). However, different cancers are caused by different muta-
gens, which generates distinct signatures of mutation. For example, muta-
tions in patients with UV-induced melanoma are dominated by C to T, while
C to A mutations are more common in lung cancers (Alexandrov et al., 2013).
Our analyses of mutations in melanoma suggest that genomic features have
better correlation with UV-radiation induced mutations (C to T) rather than
other mutation types. One limitation of our analysis is that we did not show
whether these trends we observed in melanoma are generic in other cancer
types due to limited mutations in other cancer types and the lack of tumor
cell-of-origin genomic data. We believe that a precise understanding of the
mechanism behind cancer mutation heterogeneity will serve as a foundation
to build an accurate model of mutation rate baseline. Computational meth-
57
ods aiming to prioritize driver mutations from recurrent mutations Araya
et al. (2016) might over-estimate the number of mutation hot-spots if the
genomic context of regulatory regions is ignored.
Early studies indicated that CPD is induced in DNA with the order TT
> TC + CT < CC under the UV-C radiation Setlow and Carrier (1966);
Mitchell et al. (1992). Same trends were also observed in recent genome-wide
studies. For example, Hu et al. (2015) found that the relative ratio of the
above dipyrimidines is 55:4:13:2, respectively. It has been shown that UV-B
compared with UV-C can induce more cytosine-containing pyrimidine dimer
than thymine homodimers in in vitro DNA Mitchell et al. (1992); Ellison
and Childs (1981). At low fluences of 300nm and 313nm light, cytosine-
thymine dimers (CT) were even more frequent than thymine dimer (TT)
in Escherichia coli DNA Ellison and Childs (1981). Therefore, whether the
NER dataset, in which UV-C radiation was used, is suitable to explain the
mutation heterogeneity in UV-B radiation induced melanoma remains an
unanswered question.
3.9 Methods
3.9.1 Data preparation and processing
Somatic mutation data from patients with melanoma were collected from the
International Cancer Genome Consortium (ICGC) with somatic mutations
from 183 patients with melanoma (MELA-AU project). In our analysis, only
single nucleotide variants were kept since numbers of other types of variants
are too low to reach reliable results. To make sure mutations from patients
were generated from the whole genome sequencing rather than the whole
exome sequencing, we also verified that the maximum percent of mutations
locating in gene coding regions (GENCODE V19) is 1.3% among 183 pa-
tients.
Consolidated DHS signal, histone modification ChIP-seq, and chromHMM
states from the primary cell type E059 (Foreskin Melanocyte primary cell)
were downloaded from the Roadmap Epigenomics Project. We used E059 cell
because Polak et al. (2015a) demonstrated that mutation variations correlate
better with chromatin profile from the cell origin of the tumor cell. Repli-
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cation timing data from the NHEK cell line (normal human keratinocytes)
was downloaded from the ENCODE project. GERP conservation scores
and human genome sequence for hg19 were downloaded from the UCSC
Genome Browser. Nucleosome occupancy profiling of H1 cell (human em-
bryonic stem cell) was downloaded from GEO (id:GSM119422016). Prede-
fined locations of permissive and ubiquitous enhancer were downloaded from
http://enhancer.binf.ku.dk/presets.
Genome-wide mapping of nucleotide excision repair data generated by
XR-seq was obtained from GSE67941, including two kinds of UV-induced
DNA damage: cyclobutane pyrimidine dimers (CPDs) and (6-4) pyrimidine-
pyrimidone photoproducts ((6-4)PPs). These data were generated from three
cell types: i) NHF1 (wild-type human fibroblast cell line), which is proficient
in both transcription-coupled repair and global genomic repair; ii) XP-C mu-
tant cell line, which lacks the global genomic repair; iii) CS-B cell line, which
lacks the transcription-coupled repair.
Genomic locations of TFBS generated by ENCODE project were down-
loaded from Sabarinathan et al. (2016).
3.9.2 DHS stratification and mutation rate ratio calculation
DHS was annotated with functional genomic features data (see above) by
custom scripts. For each DHS-center region ( X bp relative to DHS center
in both direction) the following features were computed: 1) average histone
modification; 2) average replication timing; 3) the NER activity as measured
by average XR-seq signals in the DHS-center; 4) the distance to the nearest
downstream transcription start site (TSS) (note that here down-/up-stream
is relative to the direction of gene transcription, same below) defined by GEN-
CODE V19; 5) the distance to the nearest upstream TSS; 6) the distance
to the nearest downstream transcription end site (TES); 7) the distance to
the nearest downstream TES; 8) average DNase I hypersensitivity defined
as cleavage count; 9) GC content; 10) average sequence conservation score
(GERP); 11) relative frequency of 32 trinucleotides (3-mer); 12) informa-
tion about genomic locations of DHS (Promoter: <2.5k upstream from the
TSS, Exon, Intron, 5UTR, CDS: protein coding region, 3UTR, Downstream:
<2.5k downstream from the TES, Distal: intergenic regions that are >5k
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from nearest TSS or TES, Intergenic: intergenic regions excluding Promoter
or Downstream that are<5k from the nearest TSS or TES); 13) co-occupancy
with CTCF binding sites; 14) ChromHMM annotation. For each continuous
feature, DHS was stratified into 20 groups. We ranked the genomic feature
value of DHS from the smallest to the largest, and further stratified them
into 20 equal size groups. If a tie exists between nearby groups, those groups
with same feature values were merged.
To compare mutation of DHS with surrounding regions, we compared DHS
center region (DHS-center) with DHS flanking regions (DHS-flank). DHS
flanking regions are defined as regions that is 1000bp far away from the DHS
midpoint in both directions excluding the 150bp-long DHS peak. We filtered
certain regions in DHS-center and DHS-flank to reduce the bias from the
calculation of mutation rates. Firstly, we excluded regions in DHS-center
or DHS-flank that is overlapped with: 1) protein coding regions defined by
GENCODE V19 (coding regions listed in gencode.V19.annotation.basic track
in UCSC Genome Browser); 2) Duke and DCC blacklisted regions from the
UCSC Genome Browser. Besides, regions within DHS-Flank regions that
are overlapped with any DHS peaks were excluded so that mutations in the
DHS-Flank could not be biased by mutations from nearby DHS.
Finally, for each feature, we counted the total number of mutations within
filtered genomic regions in DHS-center regions and DHS-flank regions. The
mutation rate of DHS-center or DHS-flank was computed by dividing muta-
tion count with the total number of nucleotides of DHS-center of DHS-flank,
respectively, and mutation rate ratio was defined as the ratio of mutation
rate between DHS-center and DHS-Flank. For normalization by GC con-
tent, mutation count C->N or T->N was normalized by a total number of
G/C or A/T under DHS-center and DHS-flank, and the normalized mutation
rate of DHS-center was divided by normalized mutation rate of DHS-flank
to get the final normalized mutation rate ratio.
3.10 Figures and Tables
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Table 3.1: Description and source of genomic features data set used.
Genomic data Source Cell type/Tissue Download link Comment










































NER (NHF1-CPD) PMID: 25934506 NHF1
https://www.ncbi.nlm.nih.gov/geo
/query/acc.cgi?acc=GSE67941
wild-type NHF1 skin fibroblasts
NER (NHF1-64PP) PMID: 25934506 NHF1
https://www.ncbi.nlm.nih.gov/geo
/query/acc.cgi?acc=GSE67941
wild-type NHF1 skin fibroblasts
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Figure 3.1: NER variation can not fully explain elevated mutation rate at
TSS/TFBS. Examples adapted from Perera et al. (2016a); Sabarinathan
et al. (2016) show that regions with same NER activity (black circle) have
much different mutation rate (green arrow). Although we only marked one
type of NER, the same conclusion apply to other NER types as well (not
shown here).
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Figure 3.2: Workflow for annotating DHS with functional genomic data,
stratifying DHS into vigintile, and computing mutation rate around DHS
center.
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Figure 3.3: Somatic mutation variations at DHS are associated with ge-
nomic features. (A) Mutation rate ratio between DHS-center and DHS-flank
varies under different genomic context. Genomic features (rows) can be pos-
itively/negatively correlated with mutation rate ratio. For each genomic fea-
ture, the entire set of DHS was stratified into 20 equal-sized groups (columns)
based on the feature value distribution. Color spectrum represents log2 mu-
tation rate ratio. (B) Mutation rate profiles around DHS peak center differs
across strata regarding DNase I hypersensitivity under DHS-center. The
X-axis shows the relative distance to DHS peak center with minus number
meaning upstream of DHS peak center. Each curve is the aggregated and
smoothed mutation rate profile calculated from one DHS stratum. Colors
of the curve indicate the quantile of DNase I hypersensitivity. As DNase I
hypersensitivity increases, the mutation rate is elevated at the center of DHS
peak while the mutation rate drops at DHS flanking region. (C) Categorical
genomic features of DHS, such as CTCF existence under DHS, ubiquitous
enhancers, and whether DHS peak is overlapped with TSS are all associated









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.4: (B) Genomic features that are negatively correlated with muta-
tion rate ratio (Cont’d)
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Figure 3.5: Mutation rate gradually elevates at DHS peak center with in-
creasing DNase I hypersensitivity. DHS are stratified based on DNase I hy-
persensitivity (DNase I cleavage count) under DHS-center region (+/-25bp
from DHS peak center) into vigintiles. For each group, raw/smoothed mu-
tation rates at each base pair from DHS peak center are shown on the left.
The orange rectangle corresponds to DHS-center region. The blue square in-
dicates DHS-Flank region ( +-/75bp to +/-1000bp from DHS peak center).
The middle panel shows the average mutation rate between DHS-center and
DHS-flank. The right panel shows mutation rate ratio of DHS-center region
versus DHS-flank region considering GC content bias between DHS-center
and DHS-flank (dark green) or not (light green).
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Figure 3.6: Mutation rate ratios are not sensitive to the choice of DHS-center
size. Scatter plots in lower-left shows the pairwise comparison of mutation
rate ratio of the same stratum between two different DHS-center sizes. Each
point in the scatter plot represents one stratum for one genomic feature. The
histogram on the diagonal represents the mutation rate ratio distribution
across different DHS-center sizes. The upper-right panel shows the Pearson
correlation coefficient calculated from the symmetrical scatter plot relative
to the diagonal.
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Figure 3.7: Patterns of mutation rate ratio under genomic features vigin-
tiles in the individual patient. Heatmap displays mutation rate ratios cal-
culated using mutations from 183 patients with melanoma or individual pa-
tient. Results derived from 183 patients mutation dataset are shown on the
left panel, including mutation rate ratio and Pearson correlation coefficient
(PCC) heatmap. The right heatmap shows PCC from the individual patient.
Patients are ordered by mutation load from high to low as shown by the bar
plot above the heatmap. Individual patients shown similar pattern compared
with entire patients (left side of heatmap) have a high percentage of C to T
mutation and UV related mutation signature.
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Figure 3.8: Patterns of mutation rate ratio under genomic features vigintiles
are correlated with mutation load and the fraction of C to T mutation. (A)
The number of genomic features with same association pattern in single
patients comparing to ensemble mutation data is positively correlated with
the number of mutations in each patient. (B) Patients with high C to T
mutations have better concordance to the ensemble results.
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Figure 3.9: The correlation trend between mutation rate ratio and the ge-
nomic features depends on mutation types. The top panel shows muta-
tion rate ratio calculated by single mutation type across vigintiles defined
by genomic features. Only C(G) to T(A) mutation type displays obvious
positive or negative trend between mutation rate ratio and genomic fea-
ture percentiles. The bottom panel shows Pearson’s correlation coefficient
(PCC) between average feature value in each stratum and mutation rate ra-
tio. Columns represent distinct definitions of DHS-center region (e.g., from
+/-15bp to +/-75bp). Note that the top panel is derived from +/-25 bp
DHS-center region. For C(G) to T(A) mutation, choosing different DHS-
center definitions do not change the trend between almost entire genomic
features and mutation rate ratio, which is not true for other mutation types.
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Figure 3.10: Mutation ratio association patterns only exist in patients with
UV radiation induced melanoma. (A) Each dot represents one patient with
X-axis representing the percentage of predicted contribution of known UV-
related mutation signature and Y-axis of the number of somatic mutations.
Patients are grouped into three groups (see Methods). (B) Heatmaps show
the vanish of monotonic associations in non-UV patients. (C) The correlation
between mutations and genomic features at megabase-scale are same in UV













































































































































































































































































































































































































































































Figure 3.11: Genomic features jointly modulate the mutation rate ratio at
DHS. (A) The heatmap shows the Pearson correlation coefficient between
genomic features and mutation rate ratio according to univariate analysis.
(B) Partial correlation coefficients between all pairwise combinations of ge-
nomic features are shown as a heatmap. The color of the heatmap indicates
the association trend between a genomic feature (row) after the effects of
a genomic feature (column) is removed. Scatter plot on the right of the
heatmap compares the correlation coefficient in univariate analysis (red bar)
and bivariate analysis (dots).
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Figure 3.12: Feature dependence index (FeDI) suggest H3K4me3, GC con-
tent, and distance to TSS as the top important genomic features. (A) FeDI
values from all pairwise combinations of genomic features are shown as a
heatmap. Boxplot above the heatmap shows the distribution of FeDI of each
column. The top and bottom of the box represent the first and third quartile.
The median is shown inside the box, and the whisker extends from box to 1.5
times height of the box. (B) Two examples show two typical relationships
between two genomic features. On the top, H3K27ac signal and ACC 3-mer
frequency additively influence the mutation rate ratio. On the bottom, GC
content under DHS-center dominates over H3K27ac on mutation rate ratio.
Genomic features with top three average FeDI score (GC content, DNase-seq
signal, and H3K4me3 signal) are highlighted using green boxes.
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Figure 3.13: Similar results were observed using DHS data from Perera et al.
(2016b). (A) The intersection of DHS from Roadmap project and Perera
et al. (2016b). (B) Promoter DHS has much higher mutation rate ratio than
enhancer DHS or the rest of DHS. (C) The trend of mutation rate regarding
DNase I hypersensitivity under the different type of DHS. The x-axis shows
the vigintiles of DHS. (D) Mutation rate ratios with distinct genomic features
are shown as a heatmap. The first heatmap on the left is the distribution we
got from Roadmap DHS. Heatmaps on the right side indicate mutation rate
ratio in different DHS groups or whole data set.
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Figure 3.14: Mutation rate ratio between H3K4me1 and H3K4me3 shows ad-
ditive interaction. Rows and columns are genomic features vigintiles. Colors
indicates mutation rate ratio. Blocks with grey color means missing data or
number of DHS peak in that vigintile combination is less than 100.
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Figure 3.15: Workflows of building a random forest model to predict mutation
rate ratio utilizing genomic features.
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Figure 3.16: Performance of the random forest model is not sensitive to the
cluster numbers used in k-means clustering. The x-axis shows the number of
clusters in k-means clustering. Y-axis shows the R-squared value (variations
explained by the model) assessed by the test set. Each point indicates result
from one test set. Upper and lower edge box represent third and first quartile.
Median is shown as the line inside the box. Whisker extends from box to
value within 1.5x of Interquartile range (distance between first and third
quartile.
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Figure 3.17: Feature importance reported by the random forest model across
genomic features. Heatmsp shows feature importance score across genomic
features (columns) in 25 test set (rows). Columns are ordered by feature
importance score from high to low with average score across test shown in
the barplot above heatmap.
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Figure 3.18: Feature selections by recursive feature elimination. Optimized
feature subset (columns) selected using recursive feature elimination in each
fitted model (rows) are shown in grey color.
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Figure 3.19: Mutation rate variations are not likely caused by heterogeneity
of NER activity at DHS. Bar plot compares the trend of mutation rate or
NER activity with genomic features vigintiles for each feature (X-axis). Y-
axis is the Pearson’s correlation coefficient between mutation rate or NER
activity and genomic features vigintiles. For genomic bins, Pearson’s corre-
lation coefficient is calculated using the average feature value and mutation
rate or average NER activity in each genomic bin.
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Figure 3.20: Distributions of mutation rate ratio between TFBS and TFBS
flanking regions with various genomic features. (A) Stacked bar plot shows
the genomic location of TFBS for CTCF-like TFBS (including CTCF,
CTCFL, RAD21, and SMC3) and other TFBS. CTCF-like TFBS are en-
riched in the distal intergenic region and are depleted in promoter and 5UTR
compared with the rest of TFBS. (B) Mutation rate ratio has a broad range
of different TFBS. Color indicates p-value of chi-square test under the null
hypothesis that mutation rate is same between TFBS and +/-1kbp flank-
ing region of TFBS. (C) The univariate analysis applied in TFBS reveals
the similar relationship of genomic features to mutation rate ratio as DHS.
(D) Three TFBS occupancy measurements (FS-Rank, PROT-Rank, and TC-
Rank) show strong positive correlation with mutation rate ratio, which can
not be seen using DNase I hypersensitivity as the proxy of TFBS binding in-
tensity. The x-axis indicates vigintiles of each feature, and Y-axis is mutation
rate ratio of each stratum.
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Figure 3.21: Combining TFBS from TF with mutation rate ratio smaller
than 1 shows similar association between genomic features and mutation
rate ratio.
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Figure 3.22: Distribution of TFBS mutation rate ratio under distinct se-
quence composition. (A) GC content of TFBS positively correlates with
mutation rate ratio across TFs. The Orange curve indicates fitted linear
curve for four types of CTCF-like TFBS. The light blue curve is obtained
using all the other TFs, and the dark blue curve is obtained after removing
NR2C2, ELK4, GAPBA and ETS1 TFs. (B) Top de novo identified motifs
in randomly selected 1000 TFBS from NR2C2, ELK4, GABPA, ETS1 and
IRF3. CGGAAG motifs are found in four out five motifs. (C) Correlations
between the 3-mer frequency of TFBS and TFBS mutation rate ratio show
good concordance with relationships revealed from DHS. Positive values indi-
cate 3-mer frequency is positively correlated with TFBS mutation rate ratio.
Negative values indicate 3-mer frequency is negatively correlated with TFBS
mutation rate ratio.
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Figure 3.23: Mutation rate and Nucleosome Occupancy Signal (NOS) around
TFBS depend on the genomic context of TFBS. For TFBS locating in distal
intergenic regions, mutation rate increased only at CTCF-like TFBS but not
in Other TFBS. On the contrary, mutation rate at TFBS in promoter region
is elevated at both CTCF-like and Other TFBS.
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CHAPTER 4
A COMPUTATIONAL TOOL FOR
ANALYZING TSA-SEQ AATA
4.1 Background
With the completion of the first draft of the human genome over a decade ago
(Lander et al., 2001), we are now able to read word-by-word of the “instruc-
tion book” of the human body. However, we have also learned that genome
does not function sequentially, but rather folded in a three-dimensional space,
allowing genomic elements located far away to interact with each other. Since
1993, many techniques based on the nuclear ligation assay (Cullen et al.,
1993) have been developed, such as 3-C based methods. Over the past two
decades, we have discovered many connections between higher levels of chro-
matin and DNA replication timing or transcriptional activity using these
techniques. Compared with traditional microscopy, these techniques have
higher resolution and throughput.
However, these 3C-based methods cannot answer one crucial question that
how far chromatin is from a specific nuclear structure. Elucidating this ques-
tion is crucial as it can shed lights on how chromatin organization orchestrates
gene expression or leads to certain diseases. For example, an abnormal gene
movement insides nucleus can cause neuropsychiatric disorders (Medrano-
Fernández and Barco, 2016). Although 3-C based methods can ideally recon-
struct the 3D positioning of chromatin, the reconstruction process requires
a lot modeling and theoretical assumptions, such as methods that can con-
vert contact frequency of a Hi-C matrix to distance in the three-dimensional
space. Lamin-DamID (Guelen et al., 2008) can only report attachment or
non-attachment rather than the cytological distance of chromatin fiber to
the nuclear lamina. Light microscopy can measure cytological distances, but
it is low throughput and low resolution. We need a method to genome-
widely measure the distance of chromatin to a target nuclear body. There
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are two challenges preventing us from quantitatively mapping chromosome
distance relative to a target nuclear structure. Take the nuclear speckle as an
example. Nuclear speckles are localized ribonucleoprotein particles termed
interchromatin granule clusters (IGC) enriched with splicing factors (Spector
and Lamond, 2011). Evidence has shown that unlike TFs which physically
bind to chromatin, nuclear speckles contain little or no DNA (Thiry, 1995).
Therefore, the first challenge we face is how to label chromatin that is phys-
ically close but not in direct contact with speckles. Additionally, a small
fraction of SON proteins might contact with DNA because SON proteins are
also involved in RNA transcription. Therefore, the second challenge is that
signals should be proportional to the total amount of target proteins given a
fixed distance range.
Recently, Dr. Andrew Belmont’s laboratory developed TSA-Seq to deal
with these two challenges. TSA-seq is a novel method which can convert
cytological distances of chromosome loci to a particular nuclear structure
into a one-dimensional continuous signal. TSA-seq utilizes tyramide signal
amplification (TSA) to generate diffusible biotin-tyramide free radicals by
attaching the horseradish peroxidase (HRP) to the secondary antibody. The
fraction of biotin-tyramide labeled DNA is proportional to the distance from
target proteins. Therefore, the ratio of biotin-tyramide labeled DNA in pull-
down sample versus the background signal from input sample is inversely
correlated with cytological distance to target proteins.
Since TSA-seq is fundamentally different from ChIP-seq, traditional data
processing and peak calling tools in ChIP-seq cannot be used for TSA-seq
data. Therefore, comprehensive characterizing TSA-seq data to transform
the raw sequencing reads to a proxy of relative distance from target pro-
tein is highly demanded. To solve this problem, in this chapter, we provide
a computational tool named Norma for automated processing of TSA-seq
data, including normalization, noise reduction strategy using spike-in, and
a stratification based analysis framework to study the correlation between
speckle proximity with genomic data. Norma takes raw sequencing reads
from pull-down and input sample and will report the genome-wide enrich-
ment score as a proxy of the distance to target proteins such as SON. The
enrichment score is determined by sliding a window along the genome mea-
suring the read density. Norma uses a scaling factor to normalize the read
depth between pulldown and input. Moreover, a more advanced normaliza-
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tion method was developed to reduce the bias from the secondary antibody
as well. We applied our methods to SON, Lamin A/C, and Lamin B TSA-seq
datasets. The genome-wide enrichment score can then be used to study the
distributions of genomic features along the lamina-speckle axis. We found
that active histone marks, highly expressed genes, and some sequence fea-
tures such as GC content are enriched in the chromatin near speckles. In
contrast, lamina-associated domains are depleted in the predicted proximity
of nuclear speckles. Our observations link the observations under the mi-
croscope with functional genomic data, providing novel insights into the 3D
organization of chromatin.
4.2 Development of a computational tool for
automated processing TSA-seq data
The overview of TSA-seq analysis procedures is illustrated in Figure 4.1.
The inputs are BAM files of aligned TSA-seq reads from the pull-down and
input. Currently, the pipeline does not have a specific requirement of how
the raw reads should be aligned to the reference genome. However, PCR
duplication removal is highly suggested if the duplication level of data is
high. We recommend examining the quality of data by some common NGS
quality control tools, such as FastQC (Andrews and Others, 2010). The
detailed procedure of preparing input data is discussed in Section 4.2.1.
The primary function of Norma is the data normalization, which is explicitly
explained in Section 4.2.2 and Section 4.2.3. After the normalization,
Norma will report a genome-wide TSA-seq enrichment score representing
the log2 ratio of the normalized pull-down read density versus the normal-
ized read density of input DNA. According to the Fick’s diffusion law, TSA
signal decays exponentially with increasing distance from target proteins.
Therefore, the enrichment score can be converted to the estimated cytologi-
cal distance by fitting the TSA-signal to real cytological distances measured
by the microscope. This was done by Fluorescence in situ hybridization
(FISH) probes targeting to dozens of genomic loci. We also incorporated
an integrative annotation process into Norma for the purpose of exploring
correlations between genomic data and the cytological distance from a tar-
get nuclear structure. Section 4.3 shows the application of Norma to map
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the genome-wide cytological distance of chromatin from nuclear speckles in
K562, and the biological knowledge we obtained from the analysis.
4.2.1 Preparing the input of TSA-seq pipeline
As illustrated in Figure 4.1, the direct input of TSA-seq processing pipeline
is the alignment file of raw reads generated by TSA-seq. Here, we describe
a general procedure of preparing the input of Norma using sequencing reads
of the SON TSA-seq data in K562 cell as an example.
Raw sequencing reads were firstly examined by FastQC (Andrews, 2010)
to make sure sequencing quality is adequate. Sequencing reads were then
mapped to the human genome (UCSC hg19) using Bowtie2 version 2.0.2
(Langmead and Salzberg, 2012) under the default parameters as shown be-
low. Chromosome Y was excluded in the reference genome to reduce the
mapping bias since the K562 cell line was derived from a female. PCR du-
plicates were removed using samtools version 0.1.19 (Li et al., 2009). Below
is an example of processing pull-down sample for SON TSA-seq.
# Since K562 is derived from a female, we remove
# chromosome Y from human reference genome hg19
# and named it hg19F
bowtie2 -p 8 -x hg19F -U SON_TSA-seq_pulldown.fastq \
-S SON_TSA-seq_pulldown.sam
# Convert Sam to Bam
samtools view -bS SON_TSA-seq_pulldown.sam \
> SON_TSA-seq_pulldown.bam
# You can also combine the above two steps if
# you do not want to save sam file on the disk using
bowtie2 -p 8 -x hg19F -U SON_TSA-seq_pulldown.fastq \
| samtools view -bS - > SON_TSA-seq_pulldown.bam
# Sort bam file
samtools sort SON_TSA-seq_pulldown.bam \
SON_TSA-seq_pulldown_sort
# remove PCR duplicate from bam file using samtools
samtools rmdup SON_TSA-seq_pulldown_sort \
SON_TSA-seq_pulldown_rmdup.bam
# Index bam file
samtools index SON_TSA-seq_pulldown_rmdup.bam
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4.2.2 TSA-seq data normalization without spike-in control
Normalization is a crucial step for NGS data analysis. Normalization can re-
move the bias from the uneven distributions of background coverage between
samples. Several reasons exist for the coverage variation, such as technical
variability, mappability of reads or intrinsic fluctuations of genomic DNA,
which is possibly caused by replication timing or copy number variation as
Figure 4.2 shown. Although many normalization methods exist for ChIP-
seq or RNA-seq data (see Landt et al. (2012); Liang and Keleş (2012); Kim
et al. (2016) for a summary), there is no methods can normalize TSA-seq
data. Nearly all the normalization methods take the sequencing library size
as the basis to build their normalization models. Among these methods, the
simplest one is sequencing depth normalization (SDN), which multiplies a
scaling factor to each sample, so that the total numbers of mapped reads in
different samples are the same. SDN scheme is simple and does not require
any assumptions about the enrichment distribution. The major drawback
for SDN, however, is that genomic region enriched with reads will reduce the
relative number of reads in background regions, which can inflate the noise
of input sample in the background regions (Landt et al., 2012). This issue
is critical in cases, where certain genomic loci have extra high enrichment.
New methods, such as the one developed by Liang and Keleş (2012), try to
correct this bias by splitting genome into signal or background regions, and
only use the background regions to obtain the scaling factor. However, since
the background regions are usually unknown prior knowledge, these tools
have to run the algorithm multiple times to report the final peaks (Liang
and Keleş, 2012).
Because TSA-seq measures the cytological distance rather than the molec-
ular contact frequency to target proteins, we found that signal variations in
TSA-seq data over large regions are much lower as compared with ChIP-seq
data Figure 4.3. Besides, over 30% of the genome has SON signal enriched
over input which means htat they are close to SON. The regions belonging
to the background are hard to tell from the browser view. Therefore, sim-
ple SDN normalization is more suitable for TSA-seq data. We developed a
sliding-window based method to normalize and calculate the genome-wide
enrichment score. The normalization procedures are as follows:
1. We divide the genome into equal-sized bins with length L. We then
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count the number of mapped reads in pull-down and input sample and
use NTSA and Ninput to represent them, respectively. The total number
of mapped reads of pull-down is TTSA, and the total number of mapped
reads of input is Tinput.
2. The normalized TSA-seq enrichment score is calculated as:






3. We slide the window towards the end of the chromosome with a step
size of s and repeat the computation of the enrichment score.
4.2.3 TSA-seq data normalization with spike-in control
Our normalization method gives reasonable results to SON TSA-seq data
as illustrated by results from Section 4.3. However, when we applied this
method to Lamin B TSA-seq, we observed that TSA score profile from the
sample without primary antibody (termed no primary control or NPC in
short) is correlated with the pull-down sample as shown in Figure 4.4.
When we checked the distributions of the secondary antibody under the
microscope, it turns out that secondary antibody has non-specific binding
towards nuclear laminas. Therefore, the enrichment score distribution we
observed in the pull-down sample is a mixture of non-specific binding of the
secondary antibody and real enrichment from the target. Inspired by some
studies in ChIP-seq analysis, we came up with an experimental procedure
to adjust the background from the secondary antibody. The experimental
procedure consists of adding a constant, low amount of foreign DNA in every
sample as an internal control. Then the signals coming from the NPC will be
subtracted in the pull-down sample before we calculate TSA-seq enrichment
scores. The normalization procedures with spike-in control are as follows:
1. We divide the genome into equal-sized bins with length L. We then
count the number of mapped read in pull-down and input sample and
used NTSA and Ninput to represent them, respectively. The total num-
ber of mapped reads in the pull-down and input sample is TTSA and
Tinput, respectively.
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2. We then use the number of reads in bin i and the expected reads in bin
i to adjust the read coverage in pull-down sample as follows:




where Ninput exp is the average read count across bins (bins without any
mapped reads are excluded).
3. Similarly, we calculate adjusted number of reads in each bin in the
NPC) sample.




Note that, the input for the NPC sample is different from the pull-down
sample.
4. The ratio of biotinylated DNA between pull-down and NPC is calcu-
lated using the spike-in control. We map the reads to spike-in control
and count the number of reads mapped to spike-in in pull-down, de-
noted STSA) and number of reads mapped to NPC, denoted SNPC),







5. The background corrected read count in the pull-down sample is:
N iTSA correct = max(0, N
i














6. Finally, the normalized and background corrected TSA-seq enrichment
score for bin i is calculated as:
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where, NaveTSA correct is the average background corrected adjusted read
count across bins.
4.2.4 Partition genome into deciles with annotations from
genomic features
Since the TSA-seq signals indicate the cytological distance, one interesting
question is how genomic features are distributed according to the relative
distance from target proteins. To answer this question, we first partition the
genome into non-overlapping 20kb bins, and take the average of TSA-seq
signal in each bin. Here, we choose the size of the bin as 20kb for the sake
of a balance between signals and noises. The signals of 20 kb bins are then
smoothed by convolution using a Hanning window of length 21 (21 x 20kb or
420kb). Thess new smoothed TSA-Seq scores with 20 kb sampling rate can
be used for SON TSA-Seq decile calculations and comparisons with other
genomic features.
The next step in our analysis pipeline is to quantify the enrichment of
genomic features across TSA-seq decile. For gene expression analysis, we
use FPKM values based on RNA-Seq data for protein-coding genes. Gene
density is calculated by taking the fraction of protein-coding genes in each
SON TSA-Seq decile. For DNase I hypersensitivity, we count the number of
DNase-seq peaks within each decile.
Histone modification and TF ChIP-seq data are classified into punctuated
peaks, broad peaks, or a mixture of punctuated and broad peaks based on
signal enrichment patterns. ChIP-seq data (H3K27ac, H3K4me1, H3K4me2,
H3K4me3, H3K79me2, H3K9ac, CTCF) with punctuated peak patterns show
sharply defined peaks of localized enrichment. ChIP-seq data (H3K27me3,
H3K36me3, H3K9me1, H3K9m3, RNA pol2) with broad peak patterns show
diffuse, widespread genomic ChIP-seq signals without discrete peaks. ChIP-
seq data with a mixture pattern of punctuated peaks and broad peak show
both local and large-scale signal enrichment (H4K20me1). The calculation
for the enrichment of histone mark across TSA-seq deciles is as follows:
1. For ChIP-Seq data with punctuated peaks, we count peak number for
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each SON TSA-Seq decile.
2. For ChIP-Seq data with broad peaks, we process the ChIP-Seq data
using a similar sliding window method as used for the TSA-Seq data
(Equation 4.8), using normalized ENCODE bigWig files for both the
ChIP and input DNA samples. NChIP is the sum of signals in a 20kb
window for the ChIP sample. Ninput is the sum of signals in a 20kb
window for the input DNA sample. ENinput is the expected value for a
20kb window based on the total number of mapped reads and the total
genome-mappable bp. NChIP norm can be interpreted as the ChIP signal
normalized by the input DNA signal. The mode of the normalized ChIP
scores NChIP norm is considered as the non-specific antibody-binding
background level, which is subtracted from the normalized score in
each 20kb window to calculate the final ChIP-Seq enrichment score
EChIP (Equation 4.8). The summed ChIP-Seq enrichment scores are





EChIP = max(0, NChIP norm −Mode(NChIP norm)) (4.9)
3. An exception is H3K9me3 for which real signal is present throughout
the genome. For this mark, the 0.5% percentile value is assumed as
background and subtracted from the normalized score.
4. For data with a mixture of sharp and broad peaks, we calculate the
total number of base pairs within the ChIP-seq peaks (peak length) in
each SON TSA decile.
4.3 Analysis TSA-seq data in K562 cell
4.3.1 Application to K562 SON TSA-seq data
Protein SON is ubiquitously expressed nuclear protein first identified from
nuclear speckle proteome (Saitoh et al., 2004; Sacco-Bubulya and Spector,
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2002). Microscopy data confirmed that SON protein is enriched at nuclear
speckles together with typical speckle markers such as ASF/SF2 (Sharma
et al., 2010). In this study, we applied TSA-seq to SON proteins to map
the genome-wide cytological distance of chromatin to nuclear speckles in
the K562 cell. Besides no primary control for testing the bias from the
secondary antibody, three variations of SON TSA-seq experiments were con-
ducted. Condition 1 was done in TSA buffer alone. Sucrose was added to
the buffer to reduce the viscosity (Condition 2) or sucrose and DTT were
added together to further reduce the viscosity (Condition 3). According to
the second Fick’s laws of diffusion, low viscosity can reduce the spreading of
TSA signals and in turn enhance enrichments. Figure 4.5 shows the genomic
TSA enrichment score in chromosome 11 using the normalization method de-
scribed in Section 4.2.2. Similar genome-wide signal profiles were observed
across three staining conditions (Figure 4.5), with pairwise Pearson’s cor-
relation coefficients > 0.6619 (see Table 4.1 for complete comparisons). In
condition 2, since the spreading of tyramide free radicals is limited, we ob-
served slightly sharper peaks and higher the dynamic range than condition 1.
Condition 3 further sharpened larger TSA peaks but reduced or eliminated
smaller peaks and flattened many valleys, as expected by the more limited
range of the free radical diffusion. We observed a reverse correlation between
SON TSA-seq signals and LaminB DamID scores across three conditions as
shown in Figure 4.5 and Table 4.1. The valleys of SON TSA-seq signals
correspond to the lamin-associated domains (LADs). While LaminB DamID
scores are bimodal, SON TSA-seq signals are unimodal and show significant
variations, which is consistent with varying distances of chromatin to nu-
clear speckles (Figure 4.6). Moreover, laminB DamID signals have a sharp
transition near the LAD boundary, whereas SON TSA-seq signals gradually
flip across X-axis with Mbp-scale transition zones (Figure 4.5, red rectan-
gles). This is consistent with the micron-scale distances between the nuclear
periphery and speckles. In summary, unlike DamID measures molecule con-
tact frequency to target proteins, TSA-seq generates genome-wide signals
indicating the relative cytological distance to target proteins. Moreover, we
have identified several cases where one end of a chromatin is very close to
nuclear speckles while the other end is far away from speckles. We verified
our predictions by labeling several genomic loci along the chromatin path
with FISH probes.
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Since TSA-seq measures cytological distance, we can directly convert TSA
signals to real cytological distances from nuclear speckles. If SON TSA sig-
nals are dominated by the spread of tyramide free-radicals from nearby speck-
les, then the dependence of SON TSA signals on the distance to speckles
should follow an exponential fit according to the diffusion model based on
the second Fick’s law. The parameters of the equations can be inferred by
FISH results from dozens of selected genomic regions. Indeed, DNA genomic
enrichments as a function of mean speckle distance for 8 FISH probes closely
matched with exponential fitting (result not shown here). Figure 4.7 shows
the predicted cytological distance of chromatin to nuclear speckles. Below
0.4 µm, cytological distances across three conditions are similar. Condition
3 has high noise when the distance is larger than 0.4µm, which we believe is
because the spread of tyramide free radicals has reached to the background
level. Using exponential fits from condition 1 and condition 2, we demon-
strated a high reproducibility of estimated speckle distances (residual mean,
median, and sd is 0.056, 0.039 and 0.062 µm, respectively). In summary,
we have proved that Norma can accurately predict cytological distance to
a target nuclear structure using TSA-seq signals and real genomic distance
information from a small number of genomic loci (8 probes in our initial
analysis of SON proteins).
4.3.2 Distribution of functional genomic data relative to
distance of nuclear speckle
Previous results have shown that at megabase scales chromatin states can be
divided into active or inactive compartments (Lieberman-Aiden et al., 2009;
Dixon et al., 2012). Regions within one type of compartment can be further
divided into sub-domains, which possess distinct gene density, lamina asso-
ciation, and CpG island occupancy (Rao et al., 2014; Roadmap Epigenomics
Consortium et al., 2015). TSA-seq provides an unprecedented opportunity
to study the distribution of these functional genomic data through a biolog-
ical meaningful axis, in essence, from close to speckles to far from speckles.
Therefore, we examined whether the distances from nuclear speckles corre-
late with various genomic features. We divided the genome into bins with a
size of 20kb and categorized these bins into deciles based on their percentiles
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of SON TSA signals. Figure 4.8 illustrates the cumulative frequency of
genomic bins versus SON TSA-seq signals, in which different color indicates
different decile, such as decile 1 has the lowest SON TSA score, and decile
10 has the highest SON TSA score.
Next, we compiled genomic features data from the ENCODE project and
other public resources (see Section 4.5). We calculated the fraction of
genomic data in each decile and displayed their relative enrichment over SON
TSA deciles (see Section 4.2.4). Figure 4.9 shows that gene size inversely
correlates with the distance from nuclear speckles, and the number of the TSS
per gene increases slightly for genes that are close to speckle. However, the
number of exons per gene and number of isoforms per gene remain constant
across SON TSA deciles. Interestingly, an increasing gradient is observed
for gene density and GC content with increasing SON TSA deciles as shown
in Figure 4.10. The positive correlation between the gene size and the
proximity to speckles might results from the increasing length of introns as
chromatin become far away from the speckle, as Bernardi (2007) showed that
length of a intron is larger in GC-poor isochores (also far away from speckle)
than GC-rich isochores.
With increasing speckle proximity, gene expressions also raise, such as
genes located in decile 10 have the highest gene expression (Figure 4.11(A-
B)). This pattern is more pronounced for top 5% expressed genes as shown
in Figure 4.11(C). Over 50% of the top 5% expressed genes are in decile
10. On the contrary, the percentage of non-expressed genes decreases with
increasing speckle proximity (Figure 4.11(B)). The enrichment of highly
expressed genes near the speckle is consistent with the biological functions
of nuclear speckles, as Spector and Lamond (2011); Shopland et al. (2003)
demonstrated that highly expressed genes are usually associated with speck-
les.
Analyses of histone modification data show a striking linear or even steeper
trend for H3K4me1/2/3, H3K27ac, H3K36me3, H3K9ac, H3K79me2 and
H3K9me1 spanning SON TSA deciles as shown in Figure 4.12(A-H). These
histone marks are all associated active gene transcriptions (Ernst and Kellis,
2012). H3K27me3 and H4K20me1 also raise with increasing nuclear prox-
imity, though they have a nearly binary division over SON TSA deciles.
Interestingly, H3K27me3 was traditionally recognized as a repressive mark
for transcription, because it is mainly catalyzed and maintained by Poly-
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comb Repressive Complex 2 (PRC2). However, Young et al. (2011) recently
revealed that H3K27me3 enrichment profiles are also correlated with tran-
scriptional activity. For example, some genes carrying H3K27me3 mark in
their promoters can still maintain high gene expression (Young et al., 2011).
In contrast, H3K9me3 signal inversely correlates with SON TSA deciles as
Figure 4.12(N) shown. Pol2, DHS, and CTCF all have similar increasing
trend over deciles (Figure 4.12(I-K)). Pol2 is an indicator of transcription
activity. CTCF is enriched in the insulator and has been shown to bed posi-
tively correlated with gene density (Kim et al., 2007). In summary, we found
that active histone, active transcription, and open chromatin regions are en-
riched in regions close to nuclear speckles while heterochromatin, repressed
regions are more likely to be found in regions far away from speckles.
According to the previous study (Medstrand et al., 2002), retrotransposons
are distributed differently across the human genome with SINE class and Alu
family enriched in gene-rich or high GC regions. Consistently, we found that
Alu elements are more enriched in segments close to nuclear speckles while
LINE (L1 and L2) and simple repeats are evenly distributed across deciles
(Figure 4.13). Meuleman et al. (2013) reported that LINE elements are
enriched in constitutive LADs by summing the coverage of LADs in LINE
elements. If we used the same method, we observed an enrichment of LINE,
L1, rather than L2 in distal regions from nuclear speckles, which is consistent
with observations from Meuleman et al. (2013). Therefore, the distributions
of repeat elements with increasing speckle proximity are consistent with pre-
vious reports about their heterogeneity along the genome. Previous stud-
ies are either based on GC content or constitutive versus facultative LADs.
Compared with their results, our results not only have a higher resolution
but also recapitulate their observations from a new angle of 3D chromatin
organization.
4.3.3 Results from SON TSA-seq suggest two types
transcription hot-zones
The binary distribution of histone modifications such as H3K9me3 suggests
that genome can be roughly divided into two kinds of functional classes:
active versus inactive. These findings are consistent with previous observa-
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tions based on combinations of histone modifications (Roadmap Epigenomics
Consortium et al., 2015) or Hi-C (Lieberman-Aiden et al., 2009). Indeed,
the distribution of LADs across SON TSA-seq deciles is almost binary with
more than 60% of LADs in the bottom three deciles as Figure 4.14(A)
shown. Note that the binary division was seen if we used LADs called from
an unmatched cell line Figure 4.14(B). This phenomenon suggests valleys
of SON TSA-seq signal represent LADs, while peaks of SON TSA-seq signal
are speckle associated regions.
However, how does this binary division correlates with the linear trend
of substantial active histone modifications is puzzling. Recently, a high res-
olution in situ Hi-C reveals six sub-compartments within traditional A,B
compartments (Rao et al., 2014). Specifically, they found two types of active
subcompartments named A1 and A2 within traditional A compartments and
four kinds of B subcompartments (B1, B2, B3, and B4). Plotting the distri-
butions of these subcompartments across SON TSA deciles reveals that A1
subcompartments and A2 subcompartments can be distinguished by their
proximity to nuclear speckles (Figure 4.15(A-B)). About 91% of A1 sub-
compartments are located at decile 9 or decile 10 but the percentage drops
to 12% for A2 subcompartments as Figure 4.15(A) shown. A1 and A2
are also quite distinguishable when we plotted the fractions of six subcom-
partments in each decile (Figure 4.15(B)). Interestingly, both observations
show that B1 subcompartments are closer to nuclear speckles than A2 sub-
compartments. When we combine regions belonging to A1 and A2 together,
a similar linear trend is revealed as shown by active transcription marks,
such as H3K4me3, H3K36me3, and Pol2 as illustrated in Figure 4.15(C-
E). Therefore, we argue that the linear trend can be explained as a mixture
of two types of transcription active regions, which probably also arise from
two kinds of nuclear spatial compartments.
If A1 and A2 are both active transcription regions, they should have com-
parable transcription activity. Figure 4.16(A-C) are scatter plots which
show SON TSA signals (x-axis) versus transcription activity represented by
RNA-seq, Pol2 intensity, and H3K36m3 in 160kb genomic bins within A1 and
A2 subcompartments. Note that the transcription activities are comparable
between A1 and A2, but their distances to the nuclear speckles are different.
Rao et al. (2014) reported a distinct association between Hi-C subcompart-
ments and replication time domains. Here, with increasing SON TSA deciles,
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we identified a striking shift towards early replication domain as shown in
Figure 4.17(A). An increasing fraction of early replicated chromatin is also
observed when we plotted the fractions of six replication domains (Figure
4.17(B)). Therefore, A1 and A2 also have distinct replication timing pro-
files. Indeed, although A1 and A2 regions with intermediate to high SON
TSA signals replicate early, A2 regions with SON TSA signal under a certain
cutoff got later replicated. Also the replication timing is linearly correlated
with the decreased SON TSA-Seq scores (Figure 4.16(D)).
In summary, analyses of SON TSA-seq data suggest the existence of two
transcriptions hot-spots with one enriched in the proximity of nuclear speck-
les and another one located farther from speckles. This model is supported by
several other observations. First, Pol2 FISH data (not shown here) demon-
strated that Pol2 proteins are not only enriched in nuclear speckles but also
can be seen at spots close to the periphery of the nucleus. Second, this
model is able to explain why genes locating at heterochromatin have high
expression. Third, and probably the most important, applying normaliza-
tion method of TSA-seq to Pol2 ChIP-seq, we identified many Pol2 hot-spots.
Interestingly, only a subset of them co-localize with the peaks of SON TSA
signals while the rest mainly co-localize with the peaks in valleys as shown in
Figure 4.18. Moreover, peaks in valleys are associated with A2 rather than
A1. Therefore, we hypothesize that regions overlapped with A1 are tran-
scription active centers near the nuclear speckles while A2 regions are small
spots far from speckles with the enrichment of transcription machinery. A2
may be closer to nuclear speckles compared with their flanking chromatin,
but they are not close to speckles.
4.3.4 Nuclear spatial-functional organization revealed from
lamina-speckle axis joint analysis
To further verify the predictions from SON TSA-seq data, we compared
SON TSA-seq data with laminA/C and laminB TSA-seq data. The overall
patterns between laminA/C and laminB are quite similar with the Pear-
son’s correlation coefficient of 0.9, and they are all reversely correlated with
SON TSA signals (Pearson’s correlation coefficients are 0.89 and 0.91, re-
spectively). Note that there is a hook-like pattern in the 2D scatter plot
102
between laminA/C and SON TSA signals (Figure 4.19), which does not
exist in the scatter plot between laminB and SON TSA signals. This im-
perfect reverse correlation might come from the fact that laminA/C proteins
are located inside nuclear interior as reported by Kind et al. (2013). Lam-
inA/C and laminB TSA-seq peaks are both associated with liminB LADs
as shown in Figure 4.20. O’Keefe et al. (1992); Pope and Gilbert (2013)
demonstrated that DNA replication timing is associated with the chromatin
architecture. We also found a gradually shift towards late replicated domains
with increasing distance from nuclear speckles (see Section 4.3.2). Our 2D
lamin-SON TSA plot demonstrates a near continuous relationship between
positions along the lamina-speckle axis and DNA replication timing (Figure
4.21). Chromatin with high laminB and low SON TSA signal has uniformly
low replication timing. Conversely, early replicated regions are exclusively
located in regions with low laminB and high SON TSA signals. Regions with
a modulated level of laminB or SON TSA-seq signal have intermediate repli-
cation timing shifting from late replicating to early replicating accompanied
by progressively increased SON TSA scores and decreased the laminB TSA-
seq scores. Finally, we intersected Hi-C subcompartments with the results of
the lamina-speckle axis. Figure 4.22 shows the distributions of Hi-C sub-
compartments along the lamina-speckle axis. Interestingly, results from the
lamina-speckle axis confirm that A2, B1, and B2 spread along the axis. In ad-
dition, B2 subcompartment is closer to speckles than A2 subcompartment.
In summary, our TSA-seq analysis reveals several types of spatial nuclear
compartments with distinct enrichment patterns of functional genomic data.
The wide spread of chromatin with intermediate levels of SON and lamin
TSA scores is very interesting. The distribution of replication timing along
the lamina-speckle axis seems to be stochastic. They may move towards to
speckles according to the environmental stimuli. We believed that the es-
timated cytological distances from a nuclear structure can help to build a
deterministic model of 3D chromatin organization.
4.4 Discussion
We demonstrated that TSA-seq can successfully measure the genome-wide
cytological distances other than molecular proximity from chromatin to a
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nuclear structure. Because signals from TSA-seq are very broad, traditional
ChIP-seq peaks calling algorithm such as Wang et al. (2013) cannot be used.
Here, we have described the first computational tool named Norma to process
and analyze TSA-seq data. With a user-defined window size, we slide the
window along the genome to calculate the enrichment of read density between
pull-down and input using SDN scheme. To remove the bias from secondary
antibodies, we have also implemented a novel normalization method taking
spike-in control into account. Genome-wide enrichment scores can then be
used to predict cytological distance, identify correlations with other genomic
data, and infer potential functions of nuclear compartments.
Applying Norma to SON TSA-seq data, we found a striking enrichment of
active histone marks, highly expressed genes, GC content, and Alu elements
with the increasing speckle proximity. Approximately 55% of the top 5% ex-
pressed genes map within an 0.4 micron mean distance (decile 10) from the
nuclear speckles. Further analyses demonstrated active transcription zones
could be spatially separated into two types transcriptionally-enriched chro-
mosome regions, corresponding to the A1 and A2 Hi-C subcompartments, re-
spectively. A1 subcompartments locate close to the nuclear speckles that are
overlapped with large peaks of SON TSA-seq signals. However, A2 subcom-
partments are associated with small peaks or peak-in-valley of SON TSA-seq
signals. Joint analysis of SON with laminA/C and laminB TSA-seq data re-
veals a reverse correlation between them and suggests the existence of the
spatial gradient distributions of replication timing and separations of Hi-C
subcompartments along the lamina-speckle axis.
There are several areas that current computational method can be further
improved. First, percentiles based method has limited power to identify the
boundaries of the speckle-associated domain (SPAD). Right now, we still do
not have a clear understanding of what is the criteria to define boundaries of
SPADs. In addition, an algorithm is needed to split large peaks into small
peaks. It is also useful to assign each peak a P value based on some statistic
model. An algorithm for identifying summit within a peak is also helpful to
determine regions that can pull the chromatin toward the nuclear speckle.
Second, we anticipate that more TSA-Seq data will be generated for other
nuclear compartments, such as the nuclear pore and the nucleolus. Lastly,
it is interesting to know which regions are constitutively associated with
speckle and which regions are associated with nuclear speckle in cell-type
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specific manner. Therefore, we will need an algorithm to robustly compare
multiple TSA-seq datasets.
4.5 Methods
4.5.1 SON TSA-Seq correlations with other genomic features
Various functional data-sets available for K562 cells were downloaded from
the ENCODE project. Genome GC content data was downloaded from the
UCSC Genome Browser and the GC fraction in each 20kb bin calculated for
each decile. We downloaded the RepeatMasker track for hg19 from the UCSC
Genome Browser to calculate numbers of different repeat types in each decile.
Replication timing and Hi-C subcompartment data from K562 and GM12878
cells, respectively, were compared with SON TSA-Seq deciles in two ways:
1.Calculating the fraction of each replication timing domain or Hi-C sub-
compartment group overlapping each SON TSA-Seq decile; 2.Calculating
the fraction of each SON TSA-Seq decile that was comprised of each repli-
cation timing domain or each Hi-C subcompartment group. For display of
replication timing, we also used the UW ENCODE Repli-Seq track (Hansen
et al., 2010) corresponding to the wavelet-smoothed signal that combines
data from different replication timing domains into one track. For analysis
of LAD distribution among the SON-TSA deciles, we first followed the al-
gorithm described previously for LAD segmentation (Guelen et al., 2008).
Adjacent LADs were then merged if more than 80% of probes of the region
between two LADs had positive log2 ratios.
4.5.2 Applying TSA-seq normalization method to Pol2
ChIP-seq data
The normalization scheme of TSA-seq data can also be applied to general
ChIP-seq data. We downloaded and processed the K562 Pol2 ChIP-seq and
input raw fastq reads from ENCODE using the same alignment pipeline as
SON TSA-seq data. Alignments from replicates were merged for the following
normalization. Since Pol2 signal should not exist on gene desert regions, we
modified the equation to calculate the normalized TSA-seq enrichment score
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as shown in Equation 4.10, where NPol2 is the number of mapped reads in
a 20kb window in Pol2 ChIP sample and TPol2 is the total number of mapped
reads of Pol2 ChIP sample (Ninput and Tinput are defined similarly for input
data). BPol2 is the expected number of reads from the background such as
non-specific binding of Pol2 to chromatin. To calculate BPol2 we first ranked
the genomic intergenic regions from longest to shortest. We considered top
5% longest intergenic regions as gene deserts. Next, we calculated average
read count per base pair within gene deserts in ChIP-seq sample. Finally,
BPol2 was calculated as the product of sliding window length and per base
pair read count from gene deserts background.






4.5.3 2D scatter plot
We created different kinds of 2D scatter plots. As for comparing SON TSA-
seq signal with other genomic functional data, we calculated average SON
TSA score per bin and average normalized read density signal per bin (except
for Repli-seq, in which we used average signal per bin from wavelet smoothed
data combining Repli-seq data from 6 time domains) and plotted them as 2D
scatter plot. As for LaminB TSA-seq and SON TSA-seq comparison, first
we calculated the average TSA-seq score per bin for SON and LaminB data
respectively and plotted them as 2D scatter plot. Then we annotated each bin
with Hi-C data and Repli-seq data to give each bin unique annotated category
for Hi-C data or average signal for Repli-seq data. For Repli-seq data, scatter
plot was further hexagon binned with color indicating the median signal
among data points inside each hexagon.
4.6 Figures and Tables
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Figure 4.1: Analysis pipeline for SON TSA-seq data in the K562 cell line.
After QC, reads were first mapped to the reference genome and PCR dupli-
cates were removed. Read density from pull-down was then normalized using
input sample producing genome-wide enrichment score (TSA-seq score). The
genome was then divided into 20kb bins and these bins were stratified into
deciles based on the average TSA-seq scores in each bin. Finally, the rela-
tionships between genomic data and TSA-seq scores are studied, which reveal
the distribution of genomic features with increasing distance from speckle.
Table 4.1: Pearson’s correlation coefficient between SON TSA-seq signal and
LaminB DamID
SON TSA-seq LaminB
DamIDCondition 1 Condition 2 Condition 3
SON TSA-seq (Condition 1) 1.0 0.9680 0.6619 -0.7603
SON TSA-seq (Condition 2) 0.9680 1.0 0.7070 -0.7262
SON TSA-seq (Condition 3) 0.6619 0.7070 1.0 -0.3617
LaminB DamID -0.7603 -0.7262 -0.3617 1.0
107
Figure 4.2: An example shows the copy number variation in the q-arm of
chromosome 22 in K562. The top track shows the reads coverage of K562
whole genome sequencing. The second track on the top shows input sample
for SON TSA-seq (Condition 2). Red box highlights amplified regions. En-
richment score normalization with input can successfully correct the bias of
coverage variations as shown in the track of SON TSA-seq enrichment score.
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Figure 4.3: ChIP-seq and TSA-seq are fundamentally different methods. A
2 Mbp view of UCSC Genome Browser on chromosome 2 illustrates the
signal difference between TSA-seq and ChIP-seq. Because TSA-seq measures
the cytological distance from target protein (e.g., SON protein), TSA-seq
signal should be proportional to spread of TSA visualized directly by light
microscopy, and this TSA signal will span large genomic regions. In contrast,
the signal of ChIP-seq is derived from multiple genomic loci where TFs have
molecular contact with DNA. ChIP-seq produces localized peaks as shown
from three ChIP-seq tracks.
Figure 4.4: Non-specific binding of secondary antibody can produce bias on
enrichment score. Although signal from no primary control are nearly flat in
SON TSA-seq experiment, signal from LaminB no primary control sample is
similar to its pull-down sample which may inflate the real signal.
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Figure 4.5: Genome-wide mapping of the distance relativ to the nuclear
speckles using TSA-Seq. UCSC Genome Browser shots shows SON TSA-
Seq enrichment score in human chromosome 11 for no primary control (top)
and the three TSA conditions versus Lamin B1 DamID data (bottom) for
comparison. Red boxes highlight more gradual transitions between SON-
TSA peaks and valleys versus inter-LAD / LAD transitions.
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Figure 4.6: DamID measures molecular proximity while TSA-seq measures
cytological proximity. Plots are histograms showing the distribution of en-
richment scores for LaminB DamID and SON TSA-seq. The Y-axis is the
number of 20kb bins in each group. The LaminB DamID signal distribution
has two apparent peak indicating whether a region is associated with lamina
or not. In contrast, histogram of SON TSA-seq signal has a unique peak
indicating the gradually changing distance from nuclear speckle.
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Figure 4.7: TSA-seq signal can accurately predict cytological distance. (A)
Estimated mean distance from nuclear speckles along chromosome 11 is cal-
culated using inverse of exponential fit of TSA signal for each of the three
TSA staining conditions. Lower speckle distance correlates with earlier DNA
replication timing, as shown by Repli-Seq data (bottom track). (B) The equa-
tion of inverse of exponential fit. (C) Histogram shows the absolute residue
calculated from distances for Conditions 1 versus 2
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Figure 4.8: Color-coding and the cut-off values for the 10 SON TSA deciles.
On the left, the curve shows the cumulative percentile of SON-TSA scores
across genome-wide 20kb bins. The definition of the SON TSA deciles and
corresponding distance is shown on the right.
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Figure 4.9: Distribution of gene architecture relative to speckle proximity.
(A)-(D) Box plots show gene architecture in each of the SON decile. Each
plot shows median (inside line), 25th (box bottom) and 75th percentiles (box
top). Upper whisker extends from 75th percentile to the highest value within
1.5-fold of the box height, and lower whisker extends from 25th percentile
to the lowest value within 1.5-fold of the box height. Outliers are marked
as black dots. With increasing speckle proximity, the gene size increases
(A), number of transcription start sites per gene increases slightly (B), the
number of exons per gene (C) and number of isoforms per gene (D) show
little change.
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Figure 4.10: With decreasing distance to speckles, gene density and GC
content increase.
Figure 4.11: Gene expression increases progressively with SON TSA deciles.
(A) Box plot shows gene expression (protein coding) in FPKM (y-axis) with
median (black line), mean (red diamond), the first and third quartile (box
bottom and box-top), whiskers equal to 1.5x box size, and outliers (black
dots). (B) In each SON TSA decile, the percentage of genes in that decile
that are highly expressed genes (top 10%, dark pink) increases while the per-
centage of non-expressed genes (black) in deciles decreases with increasing
speckle proximity. Genes expressed at near average levels (50-60%, grey)
make up a near constant fraction of expressed genes in each decile, while
genes expressed in the top 20-30% percentile (light pink) are relatively de-
pleted from the bottom 3 deciles, but otherwise show little variation in the
percentage of expressed genes that they comprise in that decile. (C) Bar plot
shows the pronounced enrichment of highly expressed gene (top 5%) in the
top decile.
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Figure 4.12: Distribution of chromatin marks as a function of distance from
speckle. (A)-(H) Active histone marks show linear gradient as a function
of distance from speckles: H3K4me1 peak count (A), H3K4me2 peak count
(B), H3K4me3 peak count (C), H3K9ac peak count (D), H3K27ac peak count
(E), H3K36me3 signal (F), H3K79me2 signal (G), and H3K9me1 signal (H).
Genomic features related to transcription also show linear gradients with
increasing distance from speckle: CTCF peak count(I), Pol2 signal (J), and
DNase-I hypersensitive sites count (K). Roughly binary division of genome
based on speckle deciles for facultative heterochromatin mark H3K27me3
(L), H4K20me1 (M) and constitutive heterochromatin mark H3K9me3 (N).
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Figure 4.13: Distribution of transposons as a function of speckle distance.
A striking linear gradient relative to speckle proximity is observed for SINE
repeat class (A) and Alu repeat family (B), in contrast with the evenly dis-
tributed LINE repeat class (D), L1, L2 repeat families (E,F) and simple
repeat class (C) in the ten SON TSA deciles.
Figure 4.14: Binary division of LADs across SON TSA-seq decile is observed
in LADs from matched cell line (A) rather than non-matched cell line (B).
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Figure 4.15: Hi-C subcompartments have distinct enrichment across SON
TSA deciles. Progressive shifts of Hi-C subcompartments relative to SON
TSA decile, displayed according to their fractions in each decile (A) versus
the relative fraction of each decile corresponding to a particular Hi-C sub-
compartment (B). Hi-C active subcompartments A1 (C) and A2 (D) show
near (A1) and intermediate (A2) speckle distance distributions which added
together reconstitute a similar gradient as seen for active marks in Figure
4.12
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Figure 4.16: A1 versus A2 subcompartments map to Mbp-scale chromosome
regions that show similarly high density of transcription but near (A1) versus
intermediate (A2) distances to nuclear speckles. Scatterplots (160 kb bin size)
and their projections (top, right) showing transcriptional activity (RNA-Seq
and Pol2 or H3K36me3) or replication timing (Repli-Seq) metrics (y axis)
versus SON TSA-Seq values (x axis) for A1 (yellow) versus A2 (purple)
regions. Red circle shows bias of highest pol II values towards higher SON
TSA-Seq scores.
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Figure 4.17: Genomic regions progressively shift to late replication time with
increasing distance from speckle displayed according to their fractions in
each decile (A) versus the relative fraction of each decile corresponding to a
particular replication timing group (B).
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Figure 4.18: Visualization of Mbp-scale chromosome regions with elevated
transcriptional activity (transcription hot-zones marked by red tick marks)
defined by smoothed normalized RNA pol2 ChIP-Seq, and their correlation
with RNA-Seq and Gro-Seq (20 kb bins), H3K36me3 ChIP, the Hi-C com-
partment eigenvector, and Repli-Seq DNA replication timing for 70 Mbp
chromosome 2 region. Smoothed normalized RNA pol2 ChIP-Seq positive
regions were matched to correlated TSA-Seq local maximums.
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Figure 4.19: (A-C) 2D TSA-Seq scatter-plots showing the relationships be-
tween Lamin A, Lamin B TSA-Seq, and SON TSA-Seq across genomic re-
gions. Each dot represents a single 300 kb bin plotted at a position cor-
responding to the average TSA-Seq values over this bin. Scatter-plots are
shown as a function of TSA-Seq values (top) or TSA-Seq quantiles (bottom).
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Figure 4.20: Inverse correlation between lamin and SON TSA-Seq. Top
to bottom: K562 cell SON TSA-Seq, Lamin B TSA-Seq, Lamin A/C TSA-
Seq, Lamin B1 DamID signal, Hi-C compartment eigenvector, SON TSA-Seq
deciles, and Hi-C subcompartment assignment for 100 Mbp chromosome 7
region.
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Figure 4.21: Replication timing progressively shift along lamina-speckle axis.
Distribution of average replication timing (DNA bin size 160 kb, color coded
for different percentiles with red showing the earliest and blue the latest) in a
2D Lamin B - SON TSA quantile histogram. Red ellipse shows slight asym-
metry in the skewing of early replicating regions disproportionally towards
higher SON TSA versus lower lamin B TSA quantiles.
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Figure 4.22: Scatterplot (320kb bin size) shows distribution of Hi-C subcom-
partments along lamina-speckle axis (Lamin B versus SON TSA-Seq). The
two active subcompartments A1 and A2 largely segregate by location along




Recent advances in high-throughput next generation sequencing (NGS) have
led to the growth of the quantity and diversity of genomic data, which pro-
vide an unprecedented opportunity to explore functions of DNA sequences
in the human genome. Today, the scope of genomic analysis has expanded
from protein-coding genes to the entire human genome. Specifically, regula-
tory regions from non-coding regions have increasingly being recognized as
the central regulator of protein-coding genes. Although the cost and time of
sequencing are no longer a problem, the bottleneck of interpreting roles of
regulatory regions is still there. The primary objective of this thesis is to ex-
plore computational approaches to handling a large amount of genomic data
related to regulatory regions and provide novel insights into their roles in
human biology. This thesis is focused on building and implementing compu-
tational approaches to extract invaluable knowledge from regulatory regions
and interpret their roles through integrated analysis with other functional
genomic data, such as ChIP-seq, DNase-seq and so on. Each part of this
thesis has a particular focal point in different dimensions.
In the first part, we have presented a probabilistic framework named AN-
TICE for predicting lineage-specific TFBS using information from MSA.
Compared with competing methods, ANTICE achieves higher accuracy on
benchmark datasets. We then applied ANTICE to 680 ChIP-seq datasets
collected from the ENCODE project. We found that a substantial pro-
portion (8.3% to 67.7%) of human TFBS have origins since the divergence
with mouse. Additionally, compared with ancestral TFBS conserved in the
human-mouse last common ancestor, younger TFBS locate farther away from
the TSS, and they are more tissue-specific. We also observed many TFBS
expansion events driven by transposons. Results of lineage-specific TFBS
provide a useful resource to understand human biology and find evidence on
how they have led to human-specific phenotypes.
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In the second part, we have studied whether the local genomic context is
associated with cancer somatic mutation rates at DHS and TFBS. We com-
prehensively examined connections between genomic features and variations
of mutation rate at DHS using mutation data compiled from 183 patients
with melanoma. We found that mutation rate ratio between DHS and its
flanking regions is strongly correlated with genomic features of DHS. In ad-
dition, we noticed that mutation rate at TFBS varies for different TFs. Re-
cently, Perera et al. (2016a); Sabarinathan et al. (2016) reported that TF
bound to chromatin could prevent NER proteins from accessing DNA, which
may be the cause of increased mutation rate at TFBS. However, our analysis
showed that variations of mutation rate at DHS cannot be fully explained
by NER activity. Results of our systematic study suggest that DNA damage
is also associated with genomic features, which could inflate the variation
of mutation rate at DHS. We believe that this work will enrich our current
understanding of cancer somatic mutations. These correlations between ge-
nomic features and mutation rates will be useful for developing a prediction
model of baseline mutation rate.
In the third part, we have presented a computational approach to prob-
ing positions of chromatin loci in the three-dimensional space. To overcome
the challenge of mapping cytological distances of chromosome loci from a
particular nuclear structure in light microscopy, our collaborators have de-
veloped the first NGS-based method aiming to measure cytological distances
of chromatin to a specific nuclear structure. We developed Norma for the
sake of processing TSA-seq data. Norma includes modules like signal normal-
ization, estimation the cytological distance, genome segmentation based on
distances, and integrated analysis of other genomic data. Applying Norma to
SON, LaminA/C, and LaminB TSA-seq data, we have obtained a genome-
wide distance map of chromatin along the speckle-lamina axis. We found
that active histone mark, highly expressed genes, and some other sequence
features such as GC content are enriched in chromatin near speckle. Ap-
plications of Norma on TSA-seq data for multiple nuclear structures should
provide novel insights into mechanisms of nuclear spatial and functional com-
partmentalization.
Although results from this thesis have provided valuable insights on roles
of regulatory regions in different dimensions, some conclusions in this the-
sis could be further explored and studied by future work. Regarding TFBS
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evolution part, our study suggests that a large number of human TFBS are
lineage-specific. However, previous studies demonstrated that primary reg-
ulatory circuits of gene regulatory network in mouse cells are maintained in
human cells (Stergachis et al., 2014). This is possible because the loss of a
TFBS in an enhancer can be functionally compensated by the appearance
of a nearby TFBS. Therefore, a natural extension of our ANTICE frame-
work is to predicate lineage-specific cis-regulatory module. In terms of the
study of associations between genomic features and cancer somatic muta-
tions, whether these trends that we observed in patients with melanoma are
generic to other cancer types is not investigated in this thesis. It would be
interesting to explore relationships between mutation rate and genomic fea-
tures across different cancer types. However, one challenge of applying our
analysis framework to other cancer types is limited cell-type specific ChIP-
seq data. Lastly, there are several aspects can be improved for Norma. 1) A
method that can distinguish large peaks from small peaks or peak-in-valley
would be helpful to more carefully A1 subcompartment and A2 subcompart-
ment. 2) We also need an algorithm to robustly comparing TSA-seq signals
from different conditions. It would be interesting to know which regions are
constitutively associated with speckles and which regions are associated with
nuclear speckle in a cell-type specific manner.
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Nik-Zainal, S., Davies, H. R., Ordoñez, G. R., Mudie, L. J., Latimer, C.,
Edkins, S., Stebbings, L., Chen, L., Jia, M., Leroy, C., Marshall, J., Men-
zies, A., Butler, A., Teague, J. W., Mangion, J., Sun, Y. A., McLaughlin,
S. F., Peckham, H. E., Tsung, E. F., Costa, G. L., Lee, C. C., Minna,
J. D., Gazdar, A., Birney, E., Rhodes, M. D., McKernan, K. J., Stratton,
M. R., Futreal, P. A. and Campbell, P. J. (2010b). A small-cell lung can-
cer genome with complex signatures of tobacco exposure. Nature 463,
184–190.
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E., San Miguel, J., Royo, R., Gelṕı, J. L., Torrents, D., Orozco, M., Pisano,
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Schuster-Böckler, B. and Lehner, B. (2012). Chromatin organization is a
major influence on regional mutation rates in human cancer cells. Nature
488, 504–507.
Sethupathy, P., Giang, H., Plotkin, J. B. and Hannenhalli, S. (2008).
Genome-wide analysis of natural selection on human cis-elements. PLoS
One 3, e3137.
Setlow, R. B. and Carrier, W. L. (1966). Pyrimidine dimers in ultraviolet-
irradiated DNA’s. J. Mol. Biol. 17, 237–254.
Sexton, T., Yaffe, E., Kenigsberg, E., Bantignies, F., Leblanc, B., Hoichman,
M., Parrinello, H., Tanay, A. and Cavalli, G. (2012). Three-dimensional
folding and functional organization principles of the Drosophila genome.
Cell 148, 458–472.
Sharma, A., Takata, H., Shibahara, K.-I., Bubulya, A. and Bubulya, P. A.
(2010). Son is essential for nuclear speckle organization and cell cycle
progression. Mol. Biol. Cell 21, 650–663.
Shibata, Y., Sheffield, N. C., Fedrigo, O., Babbitt, C. C., Wortham, M.,
Tewari, A. K., London, D., Song, L., Lee, B.-K., Iyer, V. R., Parker, S.
C. J., Margulies, E. H., Wray, G. A., Furey, T. S. and Crawford, G. E.
(2012). Extensive evolutionary changes in regulatory element activity dur-
ing human origins are associated with altered gene expression and positive
selection. PLoS Genet. 8, e1002789.
Shopland, L. S., Johnson, C. V., Byron, M., McNeil, J. and Lawrence, J. B.
(2003). Clustering of multiple specific genes and gene-rich R-bands around
SC-35 domains: evidence for local euchromatic neighborhoods. J. Cell Biol.
162, 981–990.
147
Smith, A. D., Sumazin, P. and Zhang, M. Q. (2007). Tissuespecific regulatory
elements in mammalian promoters. Mol. Syst. Biol. 3, 73.
Song, L. and Crawford, G. E. (2010). DNase-seq: a high-resolution tech-
nique for mapping active gene regulatory elements across the genome from
mammalian cells. Cold Spring Harb. Protoc. 2010, db.prot5384.
Spector, D. L. and Lamond, A. I. (2011). Nuclear speckles. Cold Spring
Harb. Perspect. Biol. 3.
Stark, A., Lin, M. F., Kheradpour, P., Pedersen, J. S., Parts, L., Carl-
son, J. W., Crosby, M. A., Rasmussen, M. D., Roy, S., Deoras, A. N.,
Ruby, J. G., Brennecke, J., Harvard FlyBase curators, Berkeley Drosophila
Genome Project, Hodges, E., Hinrichs, A. S., Caspi, A., Paten, B., Park,
S.-W., Han, M. V., Maeder, M. L., Polansky, B. J., Robson, B. E., Aerts,
S., van Helden, J., Hassan, B., Gilbert, D. G., Eastman, D. A., Rice, M.,
Weir, M., Hahn, M. W., Park, Y., Dewey, C. N., Pachter, L., Kent, W. J.,
Haussler, D., Lai, E. C., Bartel, D. P., Hannon, G. J., Kaufman, T. C.,
Eisen, M. B., Clark, A. G., Smith, D., Celniker, S. E., Gelbart, W. M.
and Kellis, M. (2007). Discovery of functional elements in 12 Drosophila
genomes using evolutionary signatures. Nature 450, 219–232.
Starling, S. (2017). Technique: SMiLE-seq illuminates transcription factor
motifs. Nat. Rev. Genet. 18, 144–145.
Stergachis, A. B., Neph, S., Sandstrom, R., Haugen, E., Reynolds, A. P.,
Zhang, M., Byron, R., Canfield, T., Stelhing-Sun, S., Lee, K., Thurman,
R. E., Vong, S., Bates, D., Neri, F., Diegel, M., Giste, E., Dunn, D.,
Vierstra, J., Hansen, R. S., Johnson, A. K., Sabo, P. J., Wilken, M. S., Reh,
T. A., Treuting, P. M., Kaul, R., Groudine, M., Bender, M. A., Borenstein,
E. and Stamatoyannopoulos, J. A. (2014). Conservation of trans-acting
circuitry during mammalian regulatory evolution. Nature 515, 365–370.
Sundaram, V., Cheng, Y., Ma, Z., Li, D., Xing, X., Edge, P., Snyder, M. P.
and Wang, T. (2014). Widespread contribution of transposable elements to
the innovation of gene regulatory networks. Genome Res. 24, 1963–1976.
Sundaram, V., Choudhary, M. N. K., Pehrsson, E., Xing, X., Fiore, C.,
Pandey, M., Maricque, B., Udawatta, M., Ngo, D., Chen, Y., Paguntalan,
A., Ray, T., Hughes, A., Cohen, B. A. and Wang, T. (2017). Functional
cis-regulatory modules encoded by mouse-specific endogenous retrovirus.
Nat. Commun. 8, 14550.
Sung, M.-H., Guertin, M. J., Baek, S. and Hager, G. L. (2014). DNase
footprint signatures are dictated by factor dynamics and DNA sequence.
Mol. Cell 56, 275–285.
148
Therizols, P., Illingworth, R. S., Courilleau, C., Boyle, S., Wood, A. J. and
Bickmore, W. A. (2014). Chromatin decondensation is sufficient to alter
nuclear organization in embryonic stem cells. Science 346, 1238–1242.
Thiry, M. (1995). The interchromatin granules. Histol. Histopathol. 10,
1035–1045.
Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T.,
Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B.,
Garg, K., John, S., Sandstrom, R., Bates, D., Boatman, L., Canfield, T. K.,
Diegel, M., Dunn, D., Ebersol, A. K., Frum, T., Giste, E., Johnson, A. K.,
Johnson, E. M., Kutyavin, T., Lajoie, B., Lee, B.-K., Lee, K., London,
D., Lotakis, D., Neph, S., Neri, F., Nguyen, E. D., Qu, H., Reynolds,
A. P., Roach, V., Safi, A., Sanchez, M. E., Sanyal, A., Shafer, A., Simon,
J. M., Song, L., Vong, S., Weaver, M., Yan, Y., Zhang, Z., Zhang, Z.,
Lenhard, B., Tewari, M., Dorschner, M. O., Hansen, R. S., Navas, P. A.,
Stamatoyannopoulos, G., Iyer, V. R., Lieb, J. D., Sunyaev, S. R., Akey,
J. M., Sabo, P. J., Kaul, R., Furey, T. S., Dekker, J., Crawford, G. E. and
Stamatoyannopoulos, J. A. (2012). The accessible chromatin landscape of
the human genome. Nature 489, 75–82.
Tommasi, S., Denissenko, M. F. and Pfeifer, G. P. (1997). Sunlight induces
pyrimidine dimers preferentially at 5-methylcytosine bases. Cancer Res.
57, 4727–4730.
van de Werken, H. J. G., Landan, G., Holwerda, S. J. B., Hoichman, M.,
Klous, P., Chachik, R., Splinter, E., Valdes-Quezada, C., Oz, Y., Bouw-
man, B. A. M., Verstegen, M. J. A. M., de Wit, E., Tanay, A. and de Laat,
W. (2012). Robust 4C-seq data analysis to screen for regulatory DNA
interactions. Nat. Methods 9, 969–972.
Vietri Rudan, M., Barrington, C., Henderson, S., Ernst, C., Odom, D. T.,
Tanay, A. and Hadjur, S. (2015). Comparative Hi-C reveals that CTCF
underlies evolution of chromosomal domain architecture. Cell Rep. 10,
1297–1309.
Wang, J., Lunyak, V. V. and Jordan, I. K. (2013). BroadPeak: a novel
algorithm for identifying broad peaks in diffuse ChIP-seq datasets. Bioin-
formatics 29, 492–493.
Wang, J., Zhuang, J., Iyer, S., Lin, X., Whitfield, T. W., Greven, M. C.,
Pierce, B. G., Dong, X., Kundaje, A., Cheng, Y., Rando, O. J., Birney,
E., Myers, R. M., Noble, W. S., Snyder, M. and Weng, Z. (2012). Sequence
features and chromatin structure around the genomic regions bound by 119
human transcription factors. Genome Res. 22, 1798–1812.
149
Weber, M., Davies, J. J., Wittig, D., Oakeley, E. J., Haase, M., Lam, W. L.
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